Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in Head Neck

Retrieve available abstracts of 465 articles:
HTML format

Single Articles

    December 2022
  1. TARLE M, Muller D, Raguz M, Luksic I, et al
    Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
    Head Neck. 2022;44:2668-2677.
    PubMed     Abstract available

  2. HONG WJ, Chang SL, Tsai CJ, Wu HC, et al
    The effect of adjuvant radiotherapy on clinical outcomes in early major salivary gland cancer.
    Head Neck. 2022;44:2865-2874.
    PubMed     Abstract available

  3. YIN LX, Routman DM, Day CN, Harmsen WS, et al
    Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer.
    Head Neck. 2022;44:2760-2768.
    PubMed     Abstract available

  4. DOS SANTOS ES, Perez-de-Oliveira ME, Normando AGC, Gueiros LAM, et al
    Systemic conditions associated with increased risk to develop oral squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2022;44:2925-2937.
    PubMed     Abstract available

  5. MOREY T, Hodge JC, Stern C, Krishnan S, et al
    Correlation between radiologic and pathologic extranodal extension in HPV-associated oropharyngeal cancer: Systematic review.
    Head Neck. 2022;44:2875-2885.
    PubMed     Abstract available

  6. MACHENS A, Lorenz K, Weber F, Dralle H, et al
    Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancer.
    Head Neck. 2022;44:2717-2726.
    PubMed     Abstract available

  7. SIDDIQ S, Stephen S, Lin D, Fox H, et al
    Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with human papillomavirus-related squamous cell cancer: Long-term results.
    Head Neck. 2022;44:2753-2759.
    PubMed     Abstract available

  8. YAN W, Liu Y, Shen C, Yi J, et al
    Elevated preradiotherapy serum lactate dehydrogenase predicts distant metastasis for lymphoepithelial carcinoma of major salivary gland following postoperative radiotherapy.
    Head Neck. 2022;44:2660-2667.
    PubMed     Abstract available

    November 2022
  9. BLAKE CL, Brown TE, Pelecanos A, Moroney LB, et al
    Enteral nutrition support and treatment toxicities in patients with head and neck cancer receiving definitive or adjuvant helical intensity-modulated radiotherapy with concurrent chemotherapy.
    Head Neck. 2022 Nov 25. doi: 10.1002/hed.27249.
    PubMed     Abstract available

  10. WANG Y, Zhang L, Zhang T, Jin S, et al
    Predictive effect of pretreatment nutritional risk and GLIM-defined malnutrition on the nutrition impact symptom clusters in patients with head and neck cancer undergoing radiotherapy.
    Head Neck. 2022 Nov 23. doi: 10.1002/hed.27250.
    PubMed     Abstract available

  11. LI W, Liu Q, Xu H, Wang H, et al
    Innovative Fudan rT staging in endoscopic surgery for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Nov 15. doi: 10.1002/hed.27244.
    PubMed     Abstract available

  12. KOTEVSKI DP, Smee RI, Vajdic CM, Field M, et al
    Empirical comparison of routinely collected electronic health record data for head and neck cancer-specific survival in machine-learnt prognostic models.
    Head Neck. 2022 Nov 11. doi: 10.1002/hed.27241.
    PubMed     Abstract available

  13. HU X, Tian T, Zhang X, Sun Q, et al
    Neutrophil-to-lymphocyte and hypopharyngeal cancer prognosis: System review and meta-analysis.
    Head Neck. 2022 Nov 11. doi: 10.1002/hed.27246.
    PubMed     Abstract available

  14. GIANNITTO C, Mercante G, Ammirabile A, Cerri L, et al
    Radiomics-based machine learning for the diagnosis of lymph node metastases in patients with head and neck cancer: Systematic review.
    Head Neck. 2022 Nov 8. doi: 10.1002/hed.27239.
    PubMed     Abstract available

  15. YEH CF, Lee WY, Yu TH, Hsu YB, et al
    Antipsychotic drug trifluoperazine as a potential therapeutic agent against nasopharyngeal carcinoma.
    Head Neck. 2022 Nov 8. doi: 10.1002/hed.27238.
    PubMed     Abstract available

  16. GIRARDI FM, Wagner VP, Martins MD, Abentroth AL, et al
    Impact of AJCC 8 pT staging in cutaneous head and neck squamous cell carcinoma in a nonselected real-world patient sample.
    Head Neck. 2022 Nov 7. doi: 10.1002/hed.27233.
    PubMed     Abstract available

  17. GOODFELLOW M, Lim C, Tustin H, Mentias Y, et al
    The diagnostic yield of head and neck imaging in symptomatic patients with a normal clinical examination.
    Head Neck. 2022;44:2564-2570.
    PubMed     Abstract available

  18. BAGUE S, Leon X, Terra X, Lejeune M, et al
    Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.
    Head Neck. 2022;44:2505-2512.
    PubMed     Abstract available

  19. VAN DEN BOSCH S, Czerwinski M, Govers T, Takes RP, et al
    Diagnostic test accuracy of sentinel lymph node biopsy in squamous cell carcinoma of the oropharynx, larynx, and hypopharynx: A systematic review and meta-analysis.
    Head Neck. 2022;44:2621-2632.
    PubMed     Abstract available

  20. DE LEO AN, Dagan R, Morris CG, Holtzman AL, et al
    Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy.
    Head Neck. 2022;44:2513-2521.
    PubMed     Abstract available

  21. TALWAR A, Gordon AJ, Bewley AF, Fancy T, et al
    Distribution of the head and neck surgical oncology workforce in the United States.
    Head Neck. 2022;44:2537-2544.
    PubMed     Abstract available

  22. MILLER JA, Moradi F, Sundaram V, Liang R, et al
    Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2491-2504.
    PubMed     Abstract available

  23. COSTANTINO A, Pace GM, Festa BM, Ferreli F, et al
    Salivary bypass tube in total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2022;44:2608-2620.
    PubMed     Abstract available

  24. MISHRA A, Shankar R, Prakash G, Banerjee S, et al
    Transposition nasolabial flap: A versatile flap for sensate reconstruction of lip defects.
    Head Neck. 2022;44:2473-2480.
    PubMed     Abstract available

  25. CHEN X, Kong D, Deng J, Mo F, et al
    Overexpression of circFNDC3B promotes the progression of oral tongue squamous cell carcinoma through the miR-1322/MED1 axis.
    Head Neck. 2022;44:2417-2427.
    PubMed     Abstract available

  26. LAN L, Wang D, Ma R, Wang W, et al
    Extracapsular dissection by the sternocleidomastoid muscle-parotid space approach reduces the risks of postparotidectomy sialocele and salivary fistula.
    Head Neck. 2022;44:2522-2527.
    PubMed     Abstract available

  27. ROMAN KM, Torabi SJ, Goshtasbi K, Kuan EC, et al
    Case volume regionalization and volume-based outcome differences in cutaneous head and neck melanoma.
    Head Neck. 2022;44:2428-2436.
    PubMed     Abstract available

  28. ZHANG D, Chai Y, Wei Y, Qi F, et al
    Survival and prognosis of metastatic head and neck adenoid cystic carcinoma.
    Head Neck. 2022;44:2407-2416.
    PubMed     Abstract available

  29. HOEBERS F, Yu E, O'Sullivan B, Postma AA, et al
    Augmenting inter-rater concordance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma: A multicenter study.
    Head Neck. 2022;44:2361-2369.
    PubMed     Abstract available

    October 2022
  30. KIM DH, Kim SW, Hwang SH
    Efficacy of optical coherence tomography in the diagnosing of oral cancerous lesion: systematic review and meta-analysis.
    Head Neck. 2022 Oct 28. doi: 10.1002/hed.27232.
    PubMed     Abstract available

  31. GALIVETI CR, Kuhnell D, Biesiada J, Zhang X, et al
    Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection.
    Head Neck. 2022 Oct 22. doi: 10.1002/hed.27231.
    PubMed     Abstract available

  32. SYKES KJ, Gibbs H, Farrokhian N, Arthur A, et al
    POINT: Pilot randomized, controlled, preoperative intervention for nutrition trial in head and neck cancer.
    Head Neck. 2022 Oct 17. doi: 10.1002/hed.27220.
    PubMed     Abstract available

  33. SANSA A, Valero C, Holgado A, Vasquez R, et al
    External validation of the H-index (host index) in patients with head and neck squamous cell carcinomas.
    Head Neck. 2022 Oct 12. doi: 10.1002/hed.27224.
    PubMed     Abstract available

  34. CHEN R, Cai Q, Lin P, Liang F, et al
    Role of immune-inflamed phenotype in the prognosis of hypopharyngeal carcinoma following primary surgery.
    Head Neck. 2022 Oct 12. doi: 10.1002/hed.27218.
    PubMed     Abstract available

  35. HE Y, Li H, Wang K, Wang J, et al
    Fourteen years old as the best age cutoff to differentiate prepubertal from pubertal papillary thyroid carcinoma.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27208.
    PubMed     Abstract available

  36. MAZUL AL, Chidambaram S, Zevallos JP, Massa ST, et al
    Disparities in head and neck cancer incidence and trends by race/ethnicity and sex.
    Head Neck. 2022 Oct 6. doi: 10.1002/hed.27209.
    PubMed     Abstract available

  37. SCHLAFSTEIN AJ, Goyal S, Amini A, Karam SD, et al
    The impact of operability status on outcomes in patients with T4 larynx cancer undergoing larynx preservation.
    Head Neck. 2022 Oct 5. doi: 10.1002/hed.27204.
    PubMed     Abstract available

  38. TIRELLI G, Gardenal N, Zanelli E, Borsetto D, et al
    Prevalence and prognostic impact of retropharyngeal lymph nodes metastases in oropharyngeal squamous cell carcinoma: Meta-analysis of published literature.
    Head Neck. 2022;44:2265-2276.
    PubMed     Abstract available

  39. FADHIL M, Singh R, Havas T, Jacobson I, et al
    Systematic review of head and neck lymphedema assessment.
    Head Neck. 2022;44:2301-2315.
    PubMed     Abstract available

  40. HADDAD G, Hueniken K, Xu MC, Bratman S, et al
    Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer.
    Head Neck. 2022;44:2181-2196.
    PubMed     Abstract available

  41. FANTINI M, Crosetti E, Pizzorni N, Sprio AE, et al
    Voice and communication after open partial horizontal laryngectomies: A cross-sectional outcome study.
    Head Neck. 2022;44:2248-2256.
    PubMed     Abstract available

  42. SANTAMARIA-BARRIA JA, Graff-Baker AN, Chang SC, Khader A, et al
    Disparities in the impact of the AJCC 8th edition staging system on differentiated thyroid cancer outcomes.
    Head Neck. 2022;44:2129-2141.
    PubMed     Abstract available

  43. SIMON C, Beharry A, Paleri V, Dubi P, et al
    The robotic-assisted extended "Sistrunk" approach for tumors of the upper aerodigestive tract with limited transoral access: First description of oncological and functional outcomes.
    Head Neck. 2022;44:2335-2341.
    PubMed     Abstract available

  44. FISHER R, Ronen O
    Cytologic diagnosis of parotid gland Warthin tumor: Systematic review and meta-analysis.
    Head Neck. 2022;44:2277-2287.
    PubMed     Abstract available

    September 2022
  45. CAMPO F, Mazzola F, Bianchi G, Manciocco V, et al
    Partial laryngectomy for naive pT3N0 laryngeal cancer: Systematic review on oncological outcomes.
    Head Neck. 2022 Sep 30. doi: 10.1002/hed.27205.
    PubMed     Abstract available

  46. LIN Q, Lin S, Chen W, Chen X, et al
    Controlling Nutritional Status (CONUT) score is a prognostic marker for laryngeal cancer patients with curative resection.
    Head Neck. 2022 Sep 28. doi: 10.1002/hed.27206.
    PubMed     Abstract available

  47. BAO D, Zhao Y, Liu Z, Xu H, et al
    Magnetic resonance imaging-based radiomics model for predicting radiation-induced temporal lobe injury in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Head Neck. 2022 Sep 26. doi: 10.1002/hed.27200.
    PubMed     Abstract available

  48. LEE HN, Song CM, Ji YB, Myung JK, et al
    Occult metastasis to the superficial level VI lymph nodes in papillary thyroid carcinoma.
    Head Neck. 2022 Sep 21. doi: 10.1002/hed.27191.
    PubMed     Abstract available

  49. ROJO RD, Ren JL, Lipe DN, Badr H, et al
    Neuropathic pain prevalence and risk factors in head and neck cancer survivors.
    Head Neck. 2022 Sep 21. doi: 10.1002/hed.27199.
    PubMed     Abstract available

  50. YU J, Smith J, Marwah R, Edkins O, et al
    Return to work in patients with head and neck cancer: Systematic review and meta-analysis.
    Head Neck. 2022 Sep 19. doi: 10.1002/hed.27197.
    PubMed     Abstract available

  51. BATCHELOR CJJ, Flukes SP
    Tracheostomy dependence following "organ preservation" (chemo)radiation protocol for laryngeal and hypopharyngeal cancers.
    Head Neck. 2022 Sep 19. doi: 10.1002/hed.27195.
    PubMed     Abstract available

  52. WANG Y, Yu T, Yang Z, Zhou Y, et al
    Radiomics based on magnetic resonance imaging for preoperative prediction of lymph node metastasis in head and neck cancer: Machine learning study.
    Head Neck. 2022 Sep 17. doi: 10.1002/hed.27189.
    PubMed     Abstract available

  53. WATSON LJ, Woodman SH, Ganderton D, Hutcheson KA, et al
    Development of the remote 100 ml water swallow test versus clinical assessment in patients with head and neck cancer: Do they agree?
    Head Neck. 2022 Sep 16. doi: 10.1002/hed.27194.
    PubMed     Abstract available

  54. LI R, Ye L, Zhu Y, Ding H, et al
    Induction chemotherapy of modified docetaxel, cisplatin, 5-fluorouracil for laryngeal preservation in locally advanced hypopharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2018-2029.
    PubMed     Abstract available

  55. GUO Y
    Therapy of head and neck cancer in China: Introduction to the special issue.
    Head Neck. 2022;44:2007-2008.

  56. LI F, Hsueh C, Gong H, Zhu Y, et al
    The management of metastatic neck nodes following induction chemotherapy in N2/3 classification hypopharyngeal carcinoma.
    Head Neck. 2022;44:2009-2017.
    PubMed     Abstract available

  57. ZHUANG B, Xiao S, Zhang L, Wang Y, et al
    Association between body composition and survival in head and neck cancer patients undergoing radiotherapy.
    Head Neck. 2022;44:2046-2054.
    PubMed     Abstract available

  58. HENG Y, Xu C, Lin H, Zhu X, et al
    Recurrence risk stratification and treatment strategies of patients with stage IVa-b hypopharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2030-2039.
    PubMed     Abstract available

  59. LIU Y, Xue L, Xia Z, Zhang Q, et al
    Combined taxane, platinum, and cetuximab as a first-line treatment for recurrent/metastatic head and neck squamous cell carcinoma: Retrospective study.
    Head Neck. 2022;44:2040-2045.
    PubMed     Abstract available

  60. ZHANG C, Gu T, Tian Z, Wang L, et al
    Lymphoepithelial carcinoma of the parotid gland: Clinicopathological analysis of 146 cases from a single institute.
    Head Neck. 2022;44:2055-2062.
    PubMed     Abstract available

  61. FARRIS JC, Steber CR, Black PJ, Chan MD, et al
    Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures.
    Head Neck. 2022 Sep 1. doi: 10.1002/hed.27176.
    PubMed     Abstract available

    August 2022
  62. TERAZAWA K, Ohashi T, Shibata H, Ishihara T, et al
    Immune-modified Glasgow prognostic score: A new prognostic marker for head and neck cancer.
    Head Neck. 2022 Aug 23. doi: 10.1002/hed.27170.
    PubMed     Abstract available

  63. CHEN KH, Jiang YT, Zhao R, Sun YC, et al
    Development and validation of prognostic nomograms in patients with ascending type of nasopharyngeal carcinoma: A retrospective study based on SEER database.
    Head Neck. 2022 Aug 20. doi: 10.1002/hed.27172.
    PubMed     Abstract available

  64. KONUTHULA N, Do OA, Gobillot T, Rodriguez CP, et al
    Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single-institution retrospective study.
    Head Neck. 2022 Aug 5. doi: 10.1002/hed.27162.
    PubMed     Abstract available

  65. PAYNE K, Brooks J, Batis N, Taylor G, et al
    Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.
    Head Neck. 2022 Aug 5. doi: 10.1002/hed.27167.
    PubMed     Abstract available

  66. KHAIR S, Dort JC, Quan ML, Cheung WY, et al
    Validated algorithms for identifying timing of second event of oropharyngeal squamous cell carcinoma using real-world data.
    Head Neck. 2022;44:1909-1917.
    PubMed     Abstract available

  67. MATTAVELLI D, Tomasoni M, Ferrari M, Compagnoni A, et al
    Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters.
    Head Neck. 2022;44:1857-1870.
    PubMed     Abstract available

  68. SONAWANE S, Jadhav SS, Goroshi M, Krishnappa B, et al
    Percentage arterial enhancement on 2D CT in the diagnosis of primary hyperparathyroidism: A prospective validation study and potential pitfalls.
    Head Neck. 2022;44:1849-1856.
    PubMed     Abstract available

  69. STEIN E, Raval MV, Hazkani I, Reiter A, et al
    The 2015 American Thyroid Association guidelines and trends in hemithyroidectomy utilization for pediatric thyroid cancer.
    Head Neck. 2022;44:1833-1841.
    PubMed     Abstract available

  70. BICAKCI BC, Mustafayev TZ, Cetinayak O, Igdem S, et al
    Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007.
    Head Neck. 2022;44:1825-1832.
    PubMed     Abstract available

  71. KERR CE, Ferrell J, Kitano M, Koek W, et al
    Thyroid nodules of indeterminate cytology in Hispanic/Latinx patients.
    Head Neck. 2022;44:1842-1848.
    PubMed     Abstract available

  72. STRAETMANS JMJAA, Stuut M, Lacko M, Hoebers F, et al
    Additional parameters to improve the prognostic value of the 8th edition of the UICC classification for human papillomavirus-related oropharyngeal tumors.
    Head Neck. 2022;44:1799-1815.
    PubMed     Abstract available

  73. ZARRABI KK, Galloway TJ, Flieder DB, Kumar SS, et al
    Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.
    Head Neck. 2022;44:E25-E30.
    PubMed     Abstract available

  74. WEYERS BW, Birkeland AC, Marsden MA, Tam A, et al
    Intraoperative delineation of p16+ oropharyngeal carcinoma of unknown primary origin with fluorescence lifetime imaging: Preliminary report.
    Head Neck. 2022;44:1765-1776.
    PubMed     Abstract available

  75. MANNELLI G, Comini LV, Sacchetto A, Santoro R, et al
    Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review.
    Head Neck. 2022;44:1961-1975.
    PubMed     Abstract available

    July 2022
  76. DORR MC, Hoesseini A, Sewnaik A, Hardillo JA, et al
    Impact of a prognostic model for overall survival on the decision-making process in a head and neck cancer multidisciplinary consultation meeting.
    Head Neck. 2022 Jul 30. doi: 10.1002/hed.27163.
    PubMed     Abstract available

  77. BEDDOK A, Saint-Martin C, Krhili S, Eddine CA, et al
    Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: Outcomes and analysis of patterns of failure.
    Head Neck. 2022 Jul 25. doi: 10.1002/hed.27153.
    PubMed     Abstract available

  78. WANG M, Zhuoma C, Liu X, Huang Q, et al
    Loss of exosomal miR-34c-5p in cancer-associated fibroblast for the maintenance of stem-like phenotypes of laryngeal cancer cells.
    Head Neck. 2022 Jul 22. doi: 10.1002/hed.27155.
    PubMed     Abstract available

  79. MARGALIT DN, Salz T, Venchiarutti R, Milley K, et al
    Interventions for head and neck cancer survivors: Systematic review.
    Head Neck. 2022 Jul 18. doi: 10.1002/hed.27142.
    PubMed     Abstract available

  80. WILSON T, Fleischer L, Patel S, Bhatnagar A, et al
    Outcomes of curative treatment for head and neck squamous cell carcinoma in very elderly adults >/=80 years old.
    Head Neck. 2022 Jul 13. doi: 10.1002/hed.27141.
    PubMed     Abstract available

  81. KIM KN, Harton J, Mitra N, Lukens JN, et al
    Acute toxicity in patients treated with concurrent chemoradiotherapy with proton versus intensity-modulated radiation therapy for nonmetastatic head and neck cancers.
    Head Neck. 2022 Jul 13. doi: 10.1002/hed.27146.
    PubMed     Abstract available

  82. ZHOU Y, Wang J, Huang Z, Gong P, et al
    Deriving prognostic significance from a molecular subtype model of laryngeal carcinoma.
    Head Neck. 2022 Jul 9. doi: 10.1002/hed.27137.
    PubMed     Abstract available

  83. LEE MY, Lee J, Stock S, Belfiglio M, et al
    Prognostic value of computed tomography scan detection of cartilage invasion in advanced laryngeal cancer treated with primary total laryngectomy.
    Head Neck. 2022 Jul 8. doi: 10.1002/hed.27133.
    PubMed     Abstract available

  84. LEE J, Kaht D, Ali S, Johnson S, et al
    Performance of the Neck Imaging Reporting and Data System as applied by general neuroradiologists to predict recurrence of head and neck cancers.
    Head Neck. 2022 Jul 8. doi: 10.1002/hed.27138.
    PubMed     Abstract available

  85. JONES AJ, Davis KP, Novinger LJ, Bonetto A, et al
    Postoperative consequences of cancer cachexia after head and neck free flap reconstruction.
    Head Neck. 2022;44:1665-1677.
    PubMed     Abstract available

  86. HELMERS R, Milstein DMJ, Straat NF, Navran A, et al
    The impact of hyperbaric oxygen therapy on late irradiation injury in oral microcirculation.
    Head Neck. 2022;44:1646-1654.
    PubMed     Abstract available

  87. WADHAVKAR N, Jorgensen JB, Bollig CA
    Association of comorbidity score with perioperative outcomes following transoral robotic surgery: National analysis.
    Head Neck. 2022;44:1655-1664.
    PubMed     Abstract available

  88. DONG W, Horiuchi K, Noguchi E, Okamoto T, et al
    Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes.
    Head Neck. 2022;44:1623-1630.
    PubMed     Abstract available

  89. WANG R, Horwich P, Sandulache VC, Hernandez DJ, et al
    Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression.
    Head Neck. 2022;44:1520-1527.
    PubMed     Abstract available

  90. FROEHLICH MH, Shih MC, Shehee L, Kompelli AR, et al
    Systematic review of neuroendocrine carcinomas of the oropharynx.
    Head Neck. 2022;44:1725-1736.
    PubMed     Abstract available

  91. MATOS LL, Capuzzo RC, Pedruzzi PAG, Farias T, et al
    Sentinel lymph node biopsy for early squamous cell carcinoma of the lip and oral cavity: Real-world experience in Brazil.
    Head Neck. 2022;44:1604-1615.
    PubMed     Abstract available

  92. SWIECICKI PL, Bellile E, Casper K, Chinn SB, et al
    Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.
    Head Neck. 2022;44:1509-1519.
    PubMed     Abstract available

  93. KIMURA S, Noguchi H, Yoshida K, Sato H, et al
    Relationship of histamine expression with chemokine balance in the tumor microenvironment of squamous cell carcinoma of the tongue.
    Head Neck. 2022;44:1554-1562.
    PubMed     Abstract available

  94. SEO GT, Wein LE, Dowling EM, Khorsandi AS, et al
    A novel technique for management of stenosis of the postlaryngectomy stoma with preservation of a functional tracheoesophageal puncture following tracheal resection.
    Head Neck. 2022;44:1737-1741.
    PubMed     Abstract available

  95. SUAREZ AJURIA M, Gallas Torreira M, Garcia Garcia A, Marichalar Mendia X, et al
    Efficacy of different sentinel lymph node biopsy protocols in oral squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2022;44:1702-1714.
    PubMed     Abstract available

  96. DE CARVALHO KIMURA T, Henschel FAN, Carneiro MC, Santin GC, et al
    Oral metastasis as the first indication of undiscovered malignancy at a distant site: A systematic review of 413 cases.
    Head Neck. 2022;44:1715-1724.
    PubMed     Abstract available

    Exploring the impact of metabolic imaging in head and neck cancer treatment.
    Head Neck. 2022 Jul 1. doi: 10.1002/hed.27131.
    PubMed     Abstract available

    June 2022
  98. HO CM, Chen YH, Hsu WH, Wang WY, et al
    Comparative effectiveness and stage-shift effect of endoscopic exam among newly diagnosed oral cancer patients with different stages in Taiwan.
    Head Neck. 2022 Jun 25. doi: 10.1002/hed.27123.
    PubMed     Abstract available

  99. AL-QURAYSHI Z, Sullivan CB, Allison DB, Buchakjian MR, et al
    Presentation and outcomes of patients with clinically T1-2, N0 parotid mucoepidermoid carcinoma: The roles of elective neck dissection and adjuvant radiotherapy.
    Head Neck. 2022 Jun 22. doi: 10.1002/hed.27128.
    PubMed     Abstract available

  100. DAI Y, Wang Z, Yan E, Li J, et al
    Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
    Head Neck. 2022 Jun 21. doi: 10.1002/hed.27126.
    PubMed     Abstract available

  101. SHAO YF, Kim S, Cramer JD, Farhat D, et al
    African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27107.
    PubMed     Abstract available

  102. COSTANTINO A, Canali L, Festa BM, Spriano G, et al
    Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27121.
    PubMed     Abstract available

  103. DENISSOFF A, Huusko T, Ventela S, Niemela S, et al
    Exposure to alcohol and overall survival in head and neck cancer: A regional cohort study.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27125.
    PubMed     Abstract available

  104. YANG A, Tanamal P, Tibbetts K, Sumer B, et al
    Characteristics and outcomes of young patients with laryngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2022 Jun 16. doi: 10.1002/hed.27120.
    PubMed     Abstract available

  105. SCHAR MS, Omari TI, Woods CM, Footner LR, et al
    Pharyngeal tongue base augmentation for dysphagia therapy: A prospective case series in patients post head and neck cancer treatment.
    Head Neck. 2022 Jun 4. doi: 10.1002/hed.27104.
    PubMed     Abstract available

  106. CHARGI N, Breik O, Forouzanfar T, Martin T, et al
    Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27113.
    PubMed     Abstract available

  107. MAZZONI A, Cazzador D, Marioni G, Zanoletti E, et al
    Treatment of advanced squamous cell carcinoma of the external auditory canal: Critical analysis of persistent failures in diagnosis and surgery with a competing-risk model.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27111.
    PubMed     Abstract available

  108. NASSIF SJ, Sasani AR, Faller GT, Harb JL, et al
    Milan system for reporting salivary gland cytopathology: Adoption and outcomes in a community setting.
    Head Neck. 2022;44:1462-1467.
    PubMed     Abstract available

  109. ABU-SHAMA Y, Renard S, Nguyen DT, Henrot P, et al
    Descriptive analysis of recurrences of nasal intestinal-type adenocarcinomas after radiotherapy.
    Head Neck. 2022;44:1356-1367.
    PubMed     Abstract available

  110. KUSAFUKA K, Sato Y, Nakatani E, Baba S, et al
    The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.
    Head Neck. 2022;44:1430-1441.
    PubMed     Abstract available

  111. PAIK C, Osterbauer B, Sahyouni G, Park S, et al
    Thyroid tumor ratio: Improving the assessment of the impact of size in pediatric thyroid cancer.
    Head Neck. 2022;44:1342-1348.
    PubMed     Abstract available

  112. BLASCO MA, Noel CW, Truong T, Huang SH, et al
    Radiologic-pathologic correlation of major versus minor extranodal extension in oral cavity cancer.
    Head Neck. 2022;44:1422-1429.
    PubMed     Abstract available

  113. KATZ AP, Larkin R, Cohen ER, Franzmann E, et al
    Indications and outcomes for elective dissection of level V in primary parotid cancer.
    Head Neck. 2022;44:1349-1355.
    PubMed     Abstract available

  114. SHONKA DC JR, Ho A, Chintakuntlawar AV, Geiger JL, et al
    American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
    Head Neck. 2022;44:1277-1300.
    PubMed     Abstract available

  115. ELSERAGY A, Bello IO, Wahab A, Coletta RD, et al
    Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis.
    Head Neck. 2022;44:1481-1491.
    PubMed     Abstract available

  116. TSANG RK, Chan WCP, Holsinger FC, Chung JCK, et al
    Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Jun 1. doi: 10.1002/hed.27115.
    PubMed     Abstract available

    May 2022
  117. KOKSAL M, Saur L, Scafa D, Sarria G, et al
    Late toxicity-related symptoms and fraction dose affect decision regret among patients receiving adjuvant radiotherapy for head and neck cancer.
    Head Neck. 2022 May 30. doi: 10.1002/hed.27103.
    PubMed     Abstract available

  118. NABUURS CH, Kievit W, Leemans CR, Smit CFGM, et al
    Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal.
    Head Neck. 2022 May 13. doi: 10.1002/hed.27082.
    PubMed     Abstract available

  119. LEE J, Lee JJB, Cha IH, Park KR, et al
    Risk factor analysis of dental implants in patients with irradiated head and neck cancer.
    Head Neck. 2022 May 12. doi: 10.1002/hed.27080.
    PubMed     Abstract available

  120. DESHMUKH J, Chatterjee A, Dora TK, Bose S, et al
    Recurrence pattern with respect to two different dose fractionations in patients with locally advanced head and neck cancer treated with chemoradiation using image-guided volumetric arc therapy.
    Head Neck. 2022 May 10. doi: 10.1002/hed.27075.
    PubMed     Abstract available

  121. KUTUK T, McAllister NC, Rzepczynski AE, Williams A, et al
    Submandibular gland transfer for the prevention of radiation-induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era.
    Head Neck. 2022;44:1213-1222.
    PubMed     Abstract available

  122. PETRELLI F, Luciani A, Ghidini A, Cherri S, et al
    Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2022;44:1255-1266.
    PubMed     Abstract available

  123. MULLER RG, Weidenbecher M, Ludlow D
    PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1164-1171.
    PubMed     Abstract available

  124. ZHAO L, Day AT, Moon D, Avkshtol V, et al
    Survival and disease progression following solitary locoregional recurrence after head and neck radiotherapy.
    Head Neck. 2022;44:1153-1163.
    PubMed     Abstract available

  125. PEETERS F, Van Dessel J, Croonenborghs TM, Smeets M, et al
    Value of six comorbidity scales for predicting survival of patients with primary surgery for oral squamous cell carcinoma.
    Head Neck. 2022;44:1142-1152.
    PubMed     Abstract available

  126. OOMS M, Ponke L, Puladi B, Winnand P, et al
    Impact of secondary tumor-free resection margins in soft tissue on local, regional, and distant recurrence in R0-resected oral squamous cell carcinoma.
    Head Neck. 2022;44:1172-1181.
    PubMed     Abstract available

  127. STEPAN K, Craig E, Skillington SA, Deutsch BC, et al
    Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1069-1078.
    PubMed     Abstract available

  128. STEVENS MN, Gallant JN, Feldman MJ, Sermarini AJ, et al
    Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1079-1085.
    PubMed     Abstract available

    April 2022
  129. FORMAN R, Deshpande H, Burtness B, Bhatia AK, et al
    Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer with a focus on elderly or frail patients.
    Head Neck. 2022 Apr 30. doi: 10.1002/hed.27077.
    PubMed     Abstract available

  130. KOBAYASHI K, Ikeda A, Matsumoto Y, Matsumura S, et al
    Surgical technique for superselective neck dissection under local anesthesia in recurrent head and neck cancer.
    Head Neck. 2022 Apr 26. doi: 10.1002/hed.27071.
    PubMed     Abstract available

  131. LI D, Li X, Fan G, Bian G, et al
    Identification of the regulatory role of the circ_0004788/miR-515-5p/FGF2 network in nasopharyngeal carcinoma development.
    Head Neck. 2022 Apr 23. doi: 10.1002/hed.27066.
    PubMed     Abstract available

  132. EARNEST-NOBLE LB, Lipsky RS, Kuhel WI, Kutler DI, et al
    Identification of occult metastatic disease via lymphoscintigraphy-guided neck dissection in N0 oral squamous cell carcinoma.
    Head Neck. 2022 Apr 16. doi: 10.1002/hed.27059.
    PubMed     Abstract available

  133. MUKHERJEE A, Wiener HW, Griffin RL, Lenneman C, et al
    Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.
    Head Neck. 2022 Apr 9. doi: 10.1002/hed.27054.
    PubMed     Abstract available

  134. ZHANG W, Li L, Guo E, Zhou H, et al
    Inhibition of PDK1 enhances radiosensitivity and reverses epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 8. doi: 10.1002/hed.27053.
    PubMed     Abstract available

  135. KORPICS MC, Turchan WT, Koshy M, Spiotto MT, et al
    Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.
    Head Neck. 2022 Apr 7. doi: 10.1002/hed.27050.
    PubMed     Abstract available

  136. MAO M, Qiu K, Ren J, Zhao Y, et al
    The revised Pittsburgh staging system for middle ear squamous cell carcinoma: A challenging clinical dilemma.
    Head Neck. 2022 Apr 5. doi: 10.1002/hed.27047.

  137. JIN YN, Liu BQ, Peng KW, Ou XQ, et al
    The prognostic value of adding systemic inflammation response index to Epstein-Barr virus DNA in childhood nasopharyngeal carcinoma: A real-world study.
    Head Neck. 2022 Apr 4. doi: 10.1002/hed.27033.
    PubMed     Abstract available

  138. BIRKENBEUEL JL, Pang JC, Lee A, Nguyen ES, et al
    Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
    Head Neck. 2022;44:1014-1029.
    PubMed     Abstract available

  139. LEE HI, Kim JH, Lee JH, Wu HG, et al
    Reducing target volume in definitive radiotherapy for human papillomavirus-associated tonsil cancer.
    Head Neck. 2022;44:989-997.
    PubMed     Abstract available

  140. OLIVER JR, Karadaghy OA, Fassas SN, Arambula Z, et al
    Machine learning directed sentinel lymph node biopsy in cutaneous head and neck melanoma.
    Head Neck. 2022;44:975-988.
    PubMed     Abstract available

  141. ESSAT M, Cooper K, Bessey A, Clowes M, et al
    Diagnostic accuracy of conventional oral examination for detecting oral cavity cancer and potentially malignant disorders in patients with clinically evident oral lesions: Systematic review and meta-analysis.
    Head Neck. 2022;44:998-1013.
    PubMed     Abstract available

  142. AGGARWAL P, Hutcheson KA, Goepfert RP, Garden AS, et al
    Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.
    Head Neck. 2022;44:952-963.
    PubMed     Abstract available

  143. ADILBAY D, Valero C, Fitzgerald C, Yuan A, et al
    Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.
    Head Neck. 2022;44:933-942.
    PubMed     Abstract available

  144. VUONG HG, Le MK, Hassell L, Kondo T, et al
    The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes.
    Head Neck. 2022;44:926-932.
    PubMed     Abstract available

  145. BEUTE JE, Seo GT, Greenberg LA, Mundi N, et al
    Cuneiform (cuniculatum) variant of oral squamous cell carcinoma revisited: Presentation of two cases and literature review of a rare entity.
    Head Neck. 2022;44:E16-E24.
    PubMed     Abstract available

  146. YANG B, Eliot M, McClean MD, Waterboer T, et al
    DNA methylation-derived systemic inflammation indices and their association with oropharyngeal cancer risk and survival.
    Head Neck. 2022;44:904-913.
    PubMed     Abstract available

  147. PARK YM, Lim JY, Koh YW, Kim SH, et al
    Machine learning and magnetic resonance imaging radiomics for predicting human papilloma virus status and prognostic factors in oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:897-903.
    PubMed     Abstract available

  148. WU SS, Chen B, Fleming CW, Shah AA, et al
    Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.
    Head Neck. 2022;44:851-861.
    PubMed     Abstract available

  149. FERRARI M, Zanoletti E, Taboni S, Cazzador D, et al
    Resection of the internal carotid artery in selected patients affected by cancer of the skull base.
    Head Neck. 2022;44:1030-1042.
    PubMed     Abstract available

  150. BOLLIG CA, Morris B, Stubbs VC
    Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I and II human papillomavirus-negative oropharyngeal cancer.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27045.
    PubMed     Abstract available

  151. TWU CW, Lin PJ, Tsou HH, Liu YC, et al
    Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27044.
    PubMed     Abstract available

    March 2022
  152. ARBAB M, Chen YH, Tishler RB, Gunasti L, et al
    Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.
    Head Neck. 2022 Mar 31. doi: 10.1002/hed.27031.
    PubMed     Abstract available

  153. GETZ KR, Bellile E, Zarins KR, Chinn SB, et al
    The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma.
    Head Neck. 2022 Mar 25. doi: 10.1002/hed.27040.
    PubMed     Abstract available

  154. FOLEY J, Burns CL, Ward EC, Nund RL, et al
    Post-acute health care needs of people with head and neck cancer: Mapping health care services, experiences, and the impact of rurality.
    Head Neck. 2022 Mar 23. doi: 10.1002/hed.27037.
    PubMed     Abstract available

  155. GILLEY DR, Clark AD, Wieser ME, Bollig CA, et al
    Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.
    Head Neck. 2022 Mar 22. doi: 10.1002/hed.27035.
    PubMed     Abstract available

  156. ZENGA J, Awan MJ, Frei A, Petrie E, et al
    Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model.
    Head Neck. 2022 Mar 8. doi: 10.1002/hed.27028.
    PubMed     Abstract available

  157. AL-QURAYSHI Z, Ngouajio AL, Buchakjian MR
    Presentation and outcomes of patients with clinically T1-2, N0 supraglottic squamous cell carcinoma: The role of definitive radiotherapy compared to primary partial laryngectomy.
    Head Neck. 2022;44:735-744.
    PubMed     Abstract available

  158. JANIK S, Faisal M, Marijic B, Grasl S, et al
    Prognostic factors in mammary analogue secretory carcinomas of the parotid gland: Systematic review and meta-analysis.
    Head Neck. 2022;44:792-804.
    PubMed     Abstract available

  159. KINBERG EC, Garneau JC, Eljazzar R, Genden EM, et al
    Postparotidectomy sialocele: 6-year review of underlying factors.
    Head Neck. 2022;44:745-748.
    PubMed     Abstract available

  160. ORLOFF LA, Noel JE, Stack BC Jr, Russell MD, et al
    Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section w
    Head Neck. 2022;44:633-660.
    PubMed     Abstract available

  161. DEANE EC, Liu AQ, Nguyen S, Anderson DW, et al
    Synchrony in head and neck surgery: Feasibility and outcomes of simultaneous scapular free flap reconstruction.
    Head Neck. 2022;44:760-769.
    PubMed     Abstract available

  162. FENLON JB, Hutten RJ, Weil CR, Lloyd S, et al
    Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins.
    Head Neck. 2022;44:606-614.
    PubMed     Abstract available

  163. MAYLAND E, Curry JM, Wax MK, Thomas CM, et al
    Impact of preoperative and intraoperative management on outcomes in osteoradionecrosis requiring free flap reconstruction.
    Head Neck. 2022;44:698-709.
    PubMed     Abstract available

  164. KOHLER HF, Vartanian JG, Pinto CAL, da Silva Rodrigues IFP, et al
    The impact of worst pattern of invasion on the extension of surgical margins in oral squamous cell carcinoma.
    Head Neck. 2022;44:691-697.
    PubMed     Abstract available

    February 2022
  165. MICHMERHUIZEN NL, Ludwig ML, Birkeland AC, Nimmagadda S, et al
    Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27018.
    PubMed     Abstract available

  166. ALZAHRANI F, Sahovaler A, Mundi N, Rammal A, et al
    Transoral robotic surgery for the identification of unknown primary head and neck squamous cell carcinomas: Its effect on the wait and the weight.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27023.
    PubMed     Abstract available

  167. SCHACHTEL MJC, Gandhi M, Bowman JJ, Porceddu SV, et al
    Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: A single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27017.
    PubMed     Abstract available

  168. JIANG YT, Chen KH, Yang J, Liang ZG, et al
    Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 26. doi: 10.1002/hed.27011.
    PubMed     Abstract available

  169. JIANG YT, Chen KH, Liang ZG, Yang J, et al
    A nomogram based on tumor response to induction chemotherapy may predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 25. doi: 10.1002/hed.27020.
    PubMed     Abstract available

  170. KIM HAJ, Zeng PYF, Sorgini A, Shaikh MH, et al
    Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.
    Head Neck. 2022 Feb 21. doi: 10.1002/hed.27007.
    PubMed     Abstract available

  171. WENG JJ, Wei JZ, Li M, Ning LP, et al
    Prognostic value of hypothyroidism in patients undergoing intensity-modulated radiation therapy for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 16. doi: 10.1002/hed.27006.
    PubMed     Abstract available

  172. LIN W, Cao D, Dong A, Liang S, et al
    Systematic construction and external validation of an immune-related prognostic model for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 15. doi: 10.1002/hed.26996.
    PubMed     Abstract available

  173. NIGHTINGALE J, Gandhi M, Helena J, Bowman J, et al
    Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms.
    Head Neck. 2022 Feb 13. doi: 10.1002/hed.27005.
    PubMed     Abstract available

  174. YANG ZC, Luo MJ, Sun XS, Liu LT, et al
    Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26999.
    PubMed     Abstract available

  175. TAKENAKA Y, Oya R, Takemoto N, Inohara H, et al
    Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26997.
    PubMed     Abstract available

  176. VANGELOV B, Bauer J, Moses D, Smee R, et al
    The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.27000.
    PubMed     Abstract available

  177. BARRETTE LX, De Ravin E, Carey RM, Mady LJ, et al
    Reconstruction following transoral robotic surgery for head and neck cancer: Systematic review.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.26998.
    PubMed     Abstract available

  178. AHSANUDDIN S, Jin R, Sheorey L, Sawhney R, et al
    Understanding basal cell adenocarcinoma of the head and neck: Population-based study.
    Head Neck. 2022;44:483-493.
    PubMed     Abstract available

  179. STEPHEN SE, Murphy JM, Beyer FR, Sellstrom D, et al
    Early postoperative functional outcomes following transoral surgery for oropharyngeal cancer: A systematic review.
    Head Neck. 2022;44:530-547.
    PubMed     Abstract available

  180. DHERE VR, Escott CE, Tian S, Switchenko JM, et al
    The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures.
    Head Neck. 2022;44:382-390.
    PubMed     Abstract available

  181. HOROWITZ G, De Almeida JR, Berania I, Goldstein DP, et al
    Achieving negative resection margins in oral cavity cancer with masticator space involvement-Is it feasible? International collaborative study.
    Head Neck. 2022;44:453-459.
    PubMed     Abstract available

  182. KAMINAGAKURA E, Tango RN, Cruz-Perez D, Bonan R, et al
    Oral squamous cell carcinoma outcome in adolescent/young adult: Systematic review and meta-analysis.
    Head Neck. 2022;44:548-561.
    PubMed     Abstract available

  183. LAEHN SJ, LoGuidice JA, Hettinger PC, Rein LE, et al
    Postoperative depth of sedation and associated outcomes in free flap transfers to the head and neck.
    Head Neck. 2022;44:391-398.
    PubMed     Abstract available

  184. MERCHANT Y, Rao V, Ramaswamy V
    The stroma in oral potentially malignant disorders: An overlooked denominator?
    Head Neck. 2022;44:572-573.

  185. WITEK ME, Woody NM, Musunuru HB, Hill PM, et al
    Defining high-risk elective contralateral neck radiation volumes for oropharynx cancer.
    Head Neck. 2022;44:317-324.
    PubMed     Abstract available

  186. BRIL SI, Chargi N, Pezier TF, Tijink BM, et al
    Arterial calcification on preoperative computed tomography imaging as a risk factor for pharyngocutaneous fistula formation after total laryngectomy.
    Head Neck. 2022;44:307-316.
    PubMed     Abstract available

    January 2022
  187. SINGH M, Thankappan K, Balasubramanian D, Pillai V, et al
    Incorporation of adverse features in advanced oral cancer improves precision in staging and patient prognostication.
    Head Neck. 2022 Jan 31. doi: 10.1002/hed.26990.
    PubMed     Abstract available

  188. DEUNING-SMIT E, Custers JAE, Mirosevic S, Takes RP, et al
    Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.
    Head Neck. 2022 Jan 27. doi: 10.1002/hed.26985.
    PubMed     Abstract available

  189. HOYLE JM, Correya TA, Kenzik K, Francisco L, et al
    Factors associated with loss to follow-up after radiation therapy for head and neck cancer.
    Head Neck. 2022 Jan 25. doi: 10.1002/hed.26986.
    PubMed     Abstract available

  190. LIU X, Wu B, Huang J, Qin Y, et al
    Tumor factors associated with in-field failure for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Head Neck. 2022 Jan 24. doi: 10.1002/hed.26983.
    PubMed     Abstract available

  191. TUOMI L, Dotevall H, Bergquist H, Petersson K, et al
    The effect of the Shaker head-lift exercise on swallowing function following treatment for head and neck cancer: Results from a randomized, controlled trial with videofluoroscopic evaluation.
    Head Neck. 2022 Jan 23. doi: 10.1002/hed.26982.
    PubMed     Abstract available

  192. GAO P, Peng W, Hu Y
    Prognostic and clinicopathological significance of lymphocyte-to-monocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2022 Jan 20. doi: 10.1002/hed.26952.
    PubMed     Abstract available

  193. EMERSON MA, Farquhar DR, Lenze NR, Sheth S, et al
    Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients.
    Head Neck. 2022 Jan 19. doi: 10.1002/hed.26977.
    PubMed     Abstract available

  194. MASCARELLA MA, Patel T, Vendra V, Gardiner L, et al
    Poor treatment tolerance in head and neck cancer patients with low muscle mass.
    Head Neck. 2022 Jan 12. doi: 10.1002/hed.26978.
    PubMed     Abstract available

  195. MEULEMANS J, Vanermen M, Goeleven A, Clement P, et al
    Transoral robotic surgery (TORS) using the da Vinci Xi: prospective analysis of feasibility, safety, and outcomes.
    Head Neck. 2022;44:143-157.
    PubMed     Abstract available

  196. WOISARD V, Balaguer M, Fredouille C, Farinas J, et al
    Construction of an automatic score for the evaluation of speech disorders among patients treated for a cancer of the oral cavity or the oropharynx: The Carcinologic Speech Severity Index.
    Head Neck. 2022;44:71-88.
    PubMed     Abstract available

  197. BIGELOW EO, Harris J, Fakhry C, Gillison ML, et al
    Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.
    Head Neck. 2022;44:158-167.
    PubMed     Abstract available

  198. YANG ZC, Du CC, Liu T, Liu LT, et al
    Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy.
    Head Neck. 2022;44:113-121.
    PubMed     Abstract available

  199. ZHOU X, Xue D, Qiu J
    Identification of biomarkers related to glycolysis with weighted gene co-expression network analysis in oral squamous cell carcinoma.
    Head Neck. 2022;44:89-103.
    PubMed     Abstract available

  200. BRAUER PR, Byrne PJ, Prendes BL, Ku JA, et al
    Association between hypertension requiring medication and 30-day outcomes in head and neck microvascular surgery.
    Head Neck. 2022;44:168-176.
    PubMed     Abstract available

  201. RE M, Tomasetti M, Monaco F, Amati M, et al
    MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma.
    Head Neck. 2022;44:18-33.
    PubMed     Abstract available

    December 2021
  202. YANG L, Xue Y, Wei Z, Ren K, et al
    Local radiotherapy versus nonradiotherapy to distant lesions for metastatic nasopharyngeal carcinoma: A retrospective cohort study.
    Head Neck. 2021 Dec 27. doi: 10.1002/hed.26953.
    PubMed     Abstract available

  203. LANE C, Myers C, Jiang D, Cooke A, et al
    Selected functional outcomes in advanced oral cancer: Comparison of surgery alone versus surgery with postoperative radiotherapy.
    Head Neck. 2021 Dec 23. doi: 10.1002/hed.26968.
    PubMed     Abstract available

  204. Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 22. doi: 10.1002/hed.26947.

  205. MCCUSKER MG, Mehra R, Amr S, Taylor RJ, et al
    Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26965.
    PubMed     Abstract available

  206. LI W, Xu R, Zhu B, Wang H, et al
    Circular RNAs: Functions and mechanisms in nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26962.
    PubMed     Abstract available

  207. ROSAS RR, Nachbor KM, Handley N, Mathison G, et al
    Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26959.
    PubMed     Abstract available

  208. KIM MS, Malik NH, Chen H, Poon I, et al
    Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
    Head Neck. 2021 Dec 19. doi: 10.1002/hed.26948.
    PubMed     Abstract available

  209. SUN Y, Pan H, He Y, Hu C, et al
    Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26961.
    PubMed     Abstract available

  210. HAN SH, Cho D, Mohammad R, Jung YH, et al
    Use of the comprehensive geriatric assessment for the prediction of postoperative complications in elderly patients with head and neck cancer.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26958.
    PubMed     Abstract available

  211. LERE-CHEVALEYRE A, Bernadach M, Lambert C, Cassagne L, et al
    Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass.
    Head Neck. 2021 Dec 16. doi: 10.1002/hed.26954.
    PubMed     Abstract available

  212. SHEHAN JN, Alwani T, LeClair J, Mahoney TF, et al
    Social determinants of health and treatment decisions in head and neck cancer.
    Head Neck. 2021 Dec 10. doi: 10.1002/hed.26931.
    PubMed     Abstract available

  213. LIU T, Dai S, Zhang H, Zhong X, et al
    The best choice of induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma: Bayesian network meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26932.
    PubMed     Abstract available

  214. YAN F, Lao WP, Nguyen SA, Sharma AK, et al
    Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26923.
    PubMed     Abstract available

  215. JEANS EB, Shiraishi S, Manzar G, Morris LK, et al
    An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
    Head Neck. 2021 Dec 3. doi: 10.1002/hed.26937.
    PubMed     Abstract available

  216. ARANTES DAC, da Silva ACG, Freitas NMA, Lima EM, et al
    Safety and efficacy of a mucoadhesive phytomedication containing curcuminoids and Bidens pilosa L. extract in the prevention and treatment of radiochemotherapy-induced oral mucositis: Triple-blind, randomized, placebo-controlled, clinical trial.
    Head Neck. 2021;43:3922-3934.
    PubMed     Abstract available

  217. ROWINSKI E, Magne N, Fayette J, Daguenet E, et al
    Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol.
    Head Neck. 2021;43:3899-3910.
    PubMed     Abstract available

  218. LUO X, Liu S, Chen Y, Qiu X, et al
    Predicting cancer-specific mortality in patients with parotid gland carcinoma by competing risk nomogram.
    Head Neck. 2021;43:3888-3898.
    PubMed     Abstract available

  219. MEHTA MP, Prince R, Butt Z, Maxwell BE, et al
    Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer.
    Head Neck. 2021;43:3955-3965.
    PubMed     Abstract available

  220. JAKOB M, Mattes LM, Unger K, Kueffer S, et al
    Human microRNA-182-5p and kinectin 1: Potential biomarkers for prognosis in oral squamous cell carcinoma.
    Head Neck. 2021;43:3707-3719.
    PubMed     Abstract available

  221. RYBKIN A, Kang JJ, Lee A, Kitpanit S, et al
    The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers.
    Head Neck. 2021;43:3796-3809.
    PubMed     Abstract available

  222. BERG M, Adnan A, Hogmo A, Sjodin H, et al
    A national study of health-related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma.
    Head Neck. 2021;43:3843-3856.
    PubMed     Abstract available

  223. SOUSA LG, Lazar Neto F, Torman DK, Diaz EM, et al
    Therapeutic approaches and outcomes in patients with larynx or hypopharynx high-grade neuroendocrine carcinoma: A single-center retrospective analysis.
    Head Neck. 2021;43:3788-3795.
    PubMed     Abstract available

  224. CHEN TC, Lo TH, Huang HC, Wang CW, et al
    Outcomes of salvage treatment in patients with recurrent oral squamous cell carcinoma.
    Head Neck. 2021;43:3764-3774.
    PubMed     Abstract available

  225. BOUAOUD J, Schouman T, Bertolus C
    Comment to: "Head and neck osteosarcomas: An analysis of treatment trends and survival outcomes in the United States (2004-2016)".
    Head Neck. 2021;43:4018-4019.

  226. NEWTON E, Valenzuela D, Foley J, Thamboo A, et al
    Outcomes for the treatment of locoregional recurrent nasopharyngeal cancer: Systematic review and pooled analysis.
    Head Neck. 2021;43:3979-3995.
    PubMed     Abstract available

    November 2021
  227. RAVIKUMAR S, Casellas NJ, Shah S, Rieth K, et al
    Geographic disparities in head and neck cancer survival in Upstate New York 2011-2019.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26945.
    PubMed     Abstract available

  228. FENG X, Zhang T, Chou J, Liu L, et al
    Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26944.
    PubMed     Abstract available

  229. AMIN N, Maroun CA, El Asmar M, Alkhatib HH, et al
    Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26935.
    PubMed     Abstract available

  230. LI G, Xia YF, Huang YX, Okat D, et al
    Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: A cost-effectiveness analysis.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26941.
    PubMed     Abstract available

  231. CHARTERS E, Bogaardt H, Clark J, Milross C, et al
    Functional swallowing outcomes related to radiation exposure to dysphagia and aspiration-related structures in patients with head and neck cancer undergoing definitive and postoperative intensity-modulated radiotherapy.
    Head Neck. 2021 Nov 22. doi: 10.1002/hed.26936.
    PubMed     Abstract available

  232. PIAI V, Jansen F, Dahlslatt K, Verdonck-de Leeuw IM, et al
    Prevalence of neurocognitive and perceived speech deficits in patients with head and neck cancer before treatment: Associations with demographic, behavioral, and disease-related factors.
    Head Neck. 2021 Nov 19. doi: 10.1002/hed.26930.
    PubMed     Abstract available

  233. LENZE NR, Bensen JT, Farnan L, Sheth S, et al
    Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.
    Head Neck. 2021 Nov 18. doi: 10.1002/hed.26934.
    PubMed     Abstract available

  234. WU EL, Peesay T, Randall JA, Nelson LL, et al
    Increased body mass index predicts prolonged survival in patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26922.
    PubMed     Abstract available

  235. DIAO K, Wang H, Phan J
    Reply to Letter to the Editor regarding 'Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter'.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26920.

  236. WEST N, Kelly C, Kovarik J, Iqbal MS, et al
    Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26925.

  237. IOCCA O, Copelli C, Ramieri G, Zocchi J, et al
    Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis.
    Head Neck. 2021 Nov 6. doi: 10.1002/hed.26908.
    PubMed     Abstract available

  238. JING Z, Guo S, Li Y, Liang Z, et al
    FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26918.
    PubMed     Abstract available

  239. BULBUL MG, Genovese TJ, Hagan K, Rege S, et al
    Salvage surgery for recurrent squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26898.
    PubMed     Abstract available

  240. SICHERO L, Tagliabue M, Mota G, Ferreira S, et al
    Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status.
    Head Neck. 2021 Nov 2. doi: 10.1002/hed.26912.
    PubMed     Abstract available

  241. MANI S, Anbarasan S, Singh CA, Kumar R, et al
    In reference to "Surgical treatment of the neck in patients with salivary gland carcinoma".
    Head Neck. 2021;43:3697-3698.

  242. WESTERGAARD-NIELSEN M, Godballe C, Grau Eriksen J, Rosenkilde Larsen S, et al
    Reply to Letter to the Editor regarding "In reference to Surgical treatment of the neck in patients with salivary gland carcinoma".
    Head Neck. 2021;43:3699-3700.

  243. MIRZA FA, Johnson CZ, Byrd JK, Albergotti WG 3rd, et al
    Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Head Neck. 2021;43:3476-3492.
    PubMed     Abstract available

  244. VOORA RS, Stramiello JA, Sumner WA, Finegersh A, et al
    Quality improvement intervention to reduce time to postoperative radiation in head and neck free flap patients.
    Head Neck. 2021;43:3530-3539.
    PubMed     Abstract available

  245. KIERCE J, Shi Y, Klieb H, Blanas N, et al
    Identification of specific clinical risk factors associated with the malignant transformation of oral epithelial dysplasia.
    Head Neck. 2021;43:3552-3561.
    PubMed     Abstract available

  246. LUO F, Huang L, Gong X, Han Z, et al
    Microwave ablation of benign thyroid nodules: 3-year follow-up outcomes.
    Head Neck. 2021;43:3437-3447.
    PubMed     Abstract available

  247. EDMOND M, Nenclares P, Harrington K, Ap Dafydd D, et al
    What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era?
    Head Neck. 2021;43:3498-3503.
    PubMed     Abstract available

  248. ZHUANG SM, Xie LE, Pang F, Zhong QY, et al
    Role of primary tumor resection in patients with metastatic medullary thyroid cancer who have unresectable distant metastases.
    Head Neck. 2021;43:3386-3392.
    PubMed     Abstract available

  249. FANTINI M, Crosetti E, Affaniti R, Sprio AE, et al
    Preoperative prognostic factors for functional and clinical outcomes after open partial horizontal laryngectomies.
    Head Neck. 2021;43:3459-3467.
    PubMed     Abstract available

  250. AMINI A, Morgan R, Meyer E, Fakhoury K, et al
    Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
    Head Neck. 2021;43:3393-3403.
    PubMed     Abstract available

  251. KIMURA B, Nagelberg J, Koo SJ, Bykowski J, et al
    Inappropriate requesting of parathyroid scintigraphy at an academic medical center.
    Head Neck. 2021;43:3404-3407.
    PubMed     Abstract available

  252. KREINBRINK PJ, Mierzwa ML, Huth B, Redmond KP, et al
    Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II study.
    Head Neck. 2021;43:3408-3416.
    PubMed     Abstract available

  253. SOLIMENO LS, Park YM, Lim JY, Koh YW, et al
    Treatment outcomes of neoadjuvant chemotherapy and transoral robotic surgery in locoregionally advanced laryngopharyngeal carcinoma.
    Head Neck. 2021;43:3429-3436.
    PubMed     Abstract available

  254. PANDEY S, Soland TM, Bjerkli IH, Sand LP, et al
    Combined loss of expression of involucrin and cytokeratin 13 is associated with poor prognosis in squamous cell carcinoma of mobile tongue.
    Head Neck. 2021;43:3374-3385.
    PubMed     Abstract available

  255. OBERSTE M, Riders A, Abbaspour B, Kerschke L, et al
    Improvement of patient stratification in human papilloma virus-associated oropharyngeal squamous cell carcinoma by defining a multivariable risk score.
    Head Neck. 2021;43:3314-3323.
    PubMed     Abstract available

  256. SMITH DH, Raslan S, Samuels MA, Iglesias T, et al
    Current salivary biomarkers for detection of human papilloma virus-induced oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:3618-3630.
    PubMed     Abstract available

  257. DAY AT, Yang AM, Tanamal P, Blackwell JM, et al
    Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2021;43:3345-3363.
    PubMed     Abstract available

  258. QUAN DL, Sukari A, Nagasaka M, Kim H, et al
    Gastrostomy tube dependence and patient-reported quality of life outcomes based on type of treatment for human papillomavirus-associated oropharyngeal cancer: Systematic review and meta-analysis.
    Head Neck. 2021;43:3681-3696.
    PubMed     Abstract available

  259. ADEOYE J, Tan JY, Ip CM, Choi SW, et al
    "Fact or fiction?": Oral cavity cancer in nonsmoking, nonalcohol drinking patients as a distinct entity-Scoping review.
    Head Neck. 2021;43:3662-3680.
    PubMed     Abstract available

  260. MASHRAH MA, Al-Sharani HM, Al-Aroomi MA, Abdelrehem A, et al
    Surgical interventions for management of benign parotid tumors: Systematic review and network meta-analysis.
    Head Neck. 2021;43:3631-3645.
    PubMed     Abstract available

  261. ZAKRZEWSKI M, Gannon OM, Panizza BJ, Saunders NA, et al
    Human papillomavirus infection and tumor microenvironment are associated with the microbiota in patients with oropharyngeal cancers-pilot study.
    Head Neck. 2021;43:3324-3330.
    PubMed     Abstract available

  262. ANAKAPU K, Wilson M, Findlay M, Brown T, et al
    Nutritional outcomes in patients undergoing transoral robotic surgery for head and neck cancers compared to conventional open surgery. A systematic review.
    Head Neck. 2021 Nov 1. doi: 10.1002/hed.26913.
    PubMed     Abstract available

    October 2021
  263. BRIL SI, Al-Mamgani A, Chargi N, Remeijer P, et al
    The association of pretreatment low skeletal muscle mass with chemotherapy dose-limiting toxicity in patients with head and neck cancer undergoing primary chemoradiotherapy with high-dose cisplatin.
    Head Neck. 2021 Oct 29. doi: 10.1002/hed.26919.
    PubMed     Abstract available

  264. SULTANIA M, Imaduddin M, S V Deo S, Kar M, et al
    Role of metronomic therapy for advanced oral cancers and predictors of response: A multi-institutional feasibility study.
    Head Neck. 2021 Oct 28. doi: 10.1002/hed.26904.
    PubMed     Abstract available

  265. ZHOU C, Cao H, Meng X, Zhang Q, et al
    Lnc-MEG3 inhibits invasion, migration, and epithelial- mesenchymal transition of nasopharyngeal carcinoma cells by regulating sequestosome 1.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26917.
    PubMed     Abstract available

  266. NALLANI R, Smith JB, Penn JP, Bur AM, et al
    Decision regret 3 and 6 months after treatment for head and neck cancer: An observational study of associations with clinicodemographics, anxiety, and quality of life.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26911.
    PubMed     Abstract available

  267. CHINTALA S, Quist KM, Gonzalez-DeWhitt PA, Katzenellenbogen RA, et al
    High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
    Head Neck. 2021 Oct 25. doi: 10.1002/hed.26906.
    PubMed     Abstract available

  268. LIU LT, Liang YJ, Guo SS, Xie Y, et al
    Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: A study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA.
    Head Neck. 2021 Oct 12. doi: 10.1002/hed.26897.
    PubMed     Abstract available

  269. AMR S, Ioffe D, Suzuki I, Mehra R, et al
    Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 10. doi: 10.1002/hed.26893.
    PubMed     Abstract available

  270. COGNETTI DM, Johnson JM, Curry JM, Kochuparambil ST, et al
    Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 9. doi: 10.1002/hed.26885.
    PubMed     Abstract available

  271. LOU DI, Dietrich MS, Deng J, Murphy BA, et al
    Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes.
    Head Neck. 2021 Oct 7. doi: 10.1002/hed.26859.
    PubMed     Abstract available

  272. LARSEN MHH, Scott SI, Channir HI, Madsen AKO, et al
    Days alive and out of hospital following transoral robotic surgery: Cohort study of 262 patients with head and neck cancer.
    Head Neck. 2021 Oct 3. doi: 10.1002/hed.26880.
    PubMed     Abstract available

  273. HOLCOMB AJ, Richmon JD
    Surgical margins in a single-modality transoral robotic surgery: A conundrum-Reply.
    Head Neck. 2021;43:3219-3221.

  274. SHAH SB, Malik A
    Surgical margins in a single modality transoral robotic surgery-A conundrum.
    Head Neck. 2021;43:3217-3218.

  275. BASTERRA J, Oishi N, Lopez I, Otero M, et al
    Use of monopolar microelectrodes and radiofrequency in the treatment of arytenoid edema after partial horizontal laryngectomy and radiotherapy.
    Head Neck. 2021;43:3245-3248.
    PubMed     Abstract available

  276. PAI P, Tuljapurkar V, Balaji A, Mishra A, et al
    Comparative study of functional outcomes following surgical treatment of early tongue cancer.
    Head Neck. 2021;43:3142-3152.
    PubMed     Abstract available

  277. WINDON MJ, Fakhry C, Margalit DN, Dey T, et al
    Epidemiologic distinctions between base of tongue and tonsil oropharyngeal carcinomas.
    Head Neck. 2021;43:3076-3085.
    PubMed     Abstract available

  278. HE C, Liu J, Hu S, Qing H, et al
    Improvement of image quality of laryngeal squamous cell carcinoma using noise-optimized virtual monoenergetic image and nonlinear blending image algorithms in dual-energy computed tomography.
    Head Neck. 2021;43:3125-3131.
    PubMed     Abstract available

  279. UEHARA T, Doi H, Ishikawa K, Inada M, et al
    Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors.
    Head Neck. 2021;43:3132-3141.
    PubMed     Abstract available

  280. SHUKLA N, Ma Y, Megwalu UC
    The role of insurance status as a mediator of racial disparities in oropharyngeal cancer outcomes.
    Head Neck. 2021;43:3116-3124.
    PubMed     Abstract available

  281. ALSUBAIE HM, Alsini AY, Alsubaie KM, Abu-Zaid A, et al
    Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials.
    Head Neck. 2021;43:3199-3213.
    PubMed     Abstract available

  282. KARTHIK K, Dhiwakar M
    Predictors of surgical site infection and pneumonia following oral cavity tumor surgery.
    Head Neck. 2021;43:3106-3115.
    PubMed     Abstract available

  283. SUN L, Shimunov D, Tan EX, Swisher-Mcclure S, et al
    Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery.
    Head Neck. 2021;43:3053-3061.
    PubMed     Abstract available

  284. MEMBRENO PV, Luttrell JB, Mamidala MP, Schwartz DL, et al
    Outcomes of primary radiotherapy with or without chemotherapy for advanced oral cavity squamous cell carcinoma: Systematic review.
    Head Neck. 2021;43:3165-3176.
    PubMed     Abstract available

  285. ROWE LM, Connor NP, Russell JA
    Respiratory-swallow coordination in a rat model of chemoradiation.
    Head Neck. 2021;43:2954-2966.
    PubMed     Abstract available

  286. MENDELSOHN AH, Lawson G
    Single-port transoral robotic surgery hypopharyngectomy.
    Head Neck. 2021;43:3234-3237.
    PubMed     Abstract available

  287. MADY LJ, Poonia SK, Baddour K, Snyder V, et al
    Consensus of free flap complications: Using a nomenclature paradigm in microvascular head and neck reconstruction.
    Head Neck. 2021;43:3032-3041.
    PubMed     Abstract available

  288. GAINO F, Gorphe P, Vander Poorten V, Holsinger FC, et al
    Preoperative predictors of difficult oropharyngeal exposure for transoral robotic surgery: The Pharyngoscore.
    Head Neck. 2021;43:3010-3021.
    PubMed     Abstract available

  289. KING C, Elsherif N, Kirwan R, Schilling C, et al
    Serial step sections at narrow intervals with immunohistochemistry are required for accurate histological assessment of sentinel lymph node biopsy in oral squamous cell carcinoma.
    Head Neck. 2021;43:2985-2993.
    PubMed     Abstract available

  290. LAW RH, Quan DL, Stefan AJ, Peterson EL, et al
    Hyperparathyroidism subsequent to radioactive iodine therapy for Graves' disease.
    Head Neck. 2021;43:2994-3000.
    PubMed     Abstract available

  291. KIM DH, Kim GJ, Kim SW, Hwang SH, et al
    Predictive value of ipsilateral central lymph node metastasis for contralateral central lymph node metastasis in patients with thyroid cancer: Systematic review and meta-analysis.
    Head Neck. 2021;43:3177-3184.
    PubMed     Abstract available

  292. LOW CM, Balakrishnan K, Smith BM, Stokken JK, et al
    Sinonasal adenocarcinoma: Population-based analysis of demographic and socioeconomic disparities.
    Head Neck. 2021;43:2946-2953.
    PubMed     Abstract available

  293. BELTRAMINI GA, Belloni LM, Fusco N, Sacconi A, et al
    Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma.
    Head Neck. 2021;43:2876-2882.
    PubMed     Abstract available

  294. PARHAR HS, Weinstein GS, O'Malley BW Jr, Shimunov D, et al
    Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Head Neck. 2021;43:2923-2934.
    PubMed     Abstract available

  295. BARBON CEA, Yao CMKL, Alvarez CP, Goepfert RP, et al
    Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis.
    Head Neck. 2021;43:2883-2895.
    PubMed     Abstract available

  296. WONG A, Zhu D, Tong JY, Ko A, et al
    The jaw-dropping costs of oral cavity cancer malpractice.
    Head Neck. 2021;43:2869-2875.
    PubMed     Abstract available

  297. THAKAR A, Panda S, Kakkar A, Singh V, et al
    A matched pair analysis of oncological outcomes in human papillomavirus-negative oropharyngeal squamous cell carcinoma: Transoral surgery versus radiotherapy or concurrent chemoradiation.
    Head Neck. 2021;43:2896-2906.
    PubMed     Abstract available

    September 2021
  298. SANABRIA A, Pinillos P, Lira RB, Shah JP, et al
    Current therapeutic options for low-risk papillary thyroid carcinoma: A scoping evidence review.
    Head Neck. 2021 Sep 30. doi: 10.1002/hed.26883.
    PubMed     Abstract available

  299. VILASECA I, Aviles-Jurado FX, Valduvieco I, Berenguer J, et al
    Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26878.
    PubMed     Abstract available

  300. FENG G, Wang T, Xue F, Qi Y, et al
    Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26877.
    PubMed     Abstract available

  301. XU X, Ong YK, Loh WS, Anil G, et al
    Clinical predictors of internal carotid artery blowout in patients with radiated nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 24. doi: 10.1002/hed.26869.
    PubMed     Abstract available

  302. SATO MP, Otsuki N, Kitano M, Ishikawa K, et al
    Up-front neck dissection followed by chemoradiotherapy for T1-T3 hypopharyngeal cancer with advanced nodal involvement.
    Head Neck. 2021 Sep 22. doi: 10.1002/hed.26881.
    PubMed     Abstract available

  303. VAN DER ELST S, Bardash Y, Wotman M, Kraus D, et al
    The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2021 Sep 15. doi: 10.1002/hed.26868.
    PubMed     Abstract available

  304. KU PKM, Vlantis AC, Hui TSC, Yeung DCM, et al
    Assessment of pharyngeal motor function using a novel velopharyngeal squeeze maneuver and a novel endoscopic pharyngeal contraction grade scale in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 15. doi: 10.1002/hed.26871.
    PubMed     Abstract available

  305. GAO Y, Mao Y, Lu S, Tan L, et al
    Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 13. doi: 10.1002/hed.26867.
    PubMed     Abstract available

  306. METZGER K, Mrosek J, Zittel S, Pilz M, et al
    Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic.
    Head Neck. 2021 Sep 8. doi: 10.1002/hed.26858.
    PubMed     Abstract available

  307. SINGH P, McDonald L, Waldenberger D, Welslau M, et al
    Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany.
    Head Neck. 2021 Sep 6. doi: 10.1002/hed.26853.
    PubMed     Abstract available

  308. SINGH A, Rosen EB, Randazzo JD, Estilo CL, et al
    Intraoral radiation stents-Primer for clinical use in head and neck cancer therapy.
    Head Neck. 2021 Sep 4. doi: 10.1002/hed.26848.
    PubMed     Abstract available

  309. FOLEY J, Ward EC, Burns CL, Nund RL, et al
    Speech pathology service enhancement for people with head and neck cancer living in rural areas: Using a concept mapping approach to inform service change.
    Head Neck. 2021 Sep 3. doi: 10.1002/hed.26850.
    PubMed     Abstract available

  310. WANG S, Stanisce L, Begun Z, Wilson T, et al
    Osteoradionecrosis of the hyoid presenting as acute airway compromise.
    Head Neck. 2021;43:E41-E44.
    PubMed     Abstract available

  311. SAWHNEY R, Ahsanuddin S, Sheorey L, Wassef DW, et al
    Understanding giant cell sarcoma of the head and neck: A population-based study.
    Head Neck. 2021;43:2786-2794.
    PubMed     Abstract available

  312. KONISHI M, Sakamoto S, Ogawa I, Yoshioka Y, et al
    Relationships between intraoral ultrasonographic and histopathological findings in patients with tongue cancer.
    Head Neck. 2021;43:2778-2785.
    PubMed     Abstract available

  313. GILAT H, Vainer I, Avishai G, Maymon SL, et al
    Radioiodine therapy induced sialadenitis versus chronic idiopathic sialadenitis-Presentation and outcomes.
    Head Neck. 2021;43:2724-2730.
    PubMed     Abstract available

  314. MOONEY CP, Clark JR, Shannon K, Palme CE, et al
    The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma.
    Head Neck. 2021;43:2705-2711.
    PubMed     Abstract available

  315. SHINDE A, Jones B, Luu M, Li R, et al
    Factors predictive of 90-day mortality after surgical resection for oral cavity cancer: Development of a recursive partitioning analysis for risk stratification.
    Head Neck. 2021;43:2731-2739.
    PubMed     Abstract available

  316. BOEVE K, Mastik MF, Slagter-Menkema L, van Dijk BAC, et al
    Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mm.
    Head Neck. 2021;43:2688-2697.
    PubMed     Abstract available

  317. HORWICH P, Gundale A, Patin S, Flores J, et al
    Impact of smoking on stage-specific survival in human papilloma virus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2698-2704.
    PubMed     Abstract available

  318. KO CA, Fang KH, Hsu CM, Lee YC, et al
    The preoperative C-reactive protein-lymphocyte ratio and the prognosis of oral cavity squamous cell carcinoma.
    Head Neck. 2021;43:2740-2754.
    PubMed     Abstract available

  319. TURCHAN WT, Korpics MC, Rooney M, Koshy M, et al
    Impact of anatomic site of distant metastasis on survival in salivary gland cancers.
    Head Neck. 2021;43:2589-2601.
    PubMed     Abstract available

  320. YU L, Zheng M, Ren J, Hu J, et al
    Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for patients with laryngeal cicatricial stenosis: Safety and efficacy.
    Head Neck. 2021;43:2634-2643.
    PubMed     Abstract available

  321. CHAN SA, Van Abel KM, Lewis JE, Routman DM, et al
    Mucoepidermoid carcinoma of the parotid gland: Twenty-year experience in treatment and outcomes.
    Head Neck. 2021;43:2663-2671.
    PubMed     Abstract available

  322. LI H, McGill M, Putri N, Yuan A, et al
    Margin status, local control, and disease-specific survival in surgically resected parotid carcinomas with parapharyngeal extension.
    Head Neck. 2021;43:2644-2654.
    PubMed     Abstract available

    August 2021
  323. GEARING PF, Daly JF, Tang NSJ, Singh K, et al
    Risk factors for surgical site infection in free-flap reconstructive surgery for head and neck cancer: A retrospective Australian cohort study.
    Head Neck. 2021 Aug 18. doi: 10.1002/hed.26837.
    PubMed     Abstract available

  324. BHOLA NE, Njatcha C, Hu L, Lee ED, et al
    PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance.
    Head Neck. 2021 Aug 3. doi: 10.1002/hed.26827.
    PubMed     Abstract available

  325. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Reply to Letter to the Editor regarding "Surgical armamentarium for salvage laryngectomy closure reinforcements".
    Head Neck. 2021;43:2559.

  326. ARUN I, Maity N, Hameed S, Jain PV, et al
    Reply to Letter to the Editor regarding "Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma".
    Head Neck. 2021;43:2556.

  327. MAMIC M, Luksic I
    Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
    Head Neck. 2021;43:2554-2555.

  328. GALLI A, Bondi S, Canevari C, Tulli M, et al
    High-risk early-stage oral tongue squamous cell carcinoma, when free margins are not enough: Critical review.
    Head Neck. 2021;43:2510-2522.
    PubMed     Abstract available

  329. XU B, Ghossein R, Ho A, Viswanathan K, et al
    Diagnostic discrepancy in second opinion reviews of primary epithelial neoplasms involving salivary gland: An 11-year experience from a tertiary referral center focusing on useful pathologic approaches and potential clinical impacts.
    Head Neck. 2021;43:2497-2509.
    PubMed     Abstract available

  330. HOLCOMB AJ, Herberg M, Strohl M, Ochoa E, et al
    Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2434-2444.
    PubMed     Abstract available

  331. MENDERICO JUNIOR GM, Theodoro TR, Pasini FS, de Menezes Ishikawa M, et al
    MicroRNA-mediated extracellular matrix remodeling in squamous cell carcinoma of the oral cavity.
    Head Neck. 2021;43:2364-2376.
    PubMed     Abstract available

  332. KWAK MS, Eun YG, Lee JW, Lee YC, et al
    Development of a machine learning model for the prediction of nodal metastasis in early T classification oral squamous cell carcinoma: SEER-based population study.
    Head Neck. 2021;43:2316-2324.
    PubMed     Abstract available

  333. MA CY, Guo B, Shen Y, Zheng ZW, et al
    A novel application of superior thyroid artery perforator flaps for medium-sized intraoral reconstructions: Retrospective analysis of 12 cases.
    Head Neck. 2021;43:2297-2306.
    PubMed     Abstract available

  334. MOYA-PLANA A, Mangin D, Blanchard P, Obongo R, et al
    Prognostic value and therapeutic implications of nodal involvement in head and neck mucosal melanoma.
    Head Neck. 2021;43:2325-2331.
    PubMed     Abstract available

    July 2021
  335. STOKES WA, Molina E, McDermott JD, Morgan RL, et al
    Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26809.
    PubMed     Abstract available

  336. SCHLIJPER R, Bos S, Hamilton SN, Tran E, et al
    Ninety-day mortality after radiotherapy for head and neck cancer: A population-based comparison between rural and urban patients.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26819.
    PubMed     Abstract available

  337. KIM MJ, Back K, Choe JH, Kim JH, et al
    Feasibility of lateral sentinel lymph node biopsy in medullary thyroid cancer: A surrogate tool for determining prophylactic lateral neck dissection-A pilot study.
    Head Neck. 2021 Jul 20. doi: 10.1002/hed.26808.
    PubMed     Abstract available

  338. DIAO K, Nguyen TP, Moreno AC, Reddy JP, et al
    Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: A large, single-institution, modern cohort study.
    Head Neck. 2021 Jul 16. doi: 10.1002/hed.26820.
    PubMed     Abstract available

  339. THANKAPPAN K, Subramanian S, Balasubramanian D, Kuriakose MA, et al
    Cost-effectiveness of oral cancer screening approaches by visual examination: A systematic review.
    Head Neck. 2021 Jul 14. doi: 10.1002/hed.26816.
    PubMed     Abstract available

  340. DING Z, Li Y, Pan X, Xuan M, et al
    Sentinel lymph node biopsy versus elective neck dissection in squamous cell carcinoma of the oral cavity with a clinically N0 neck: A systematic review and meta-analysis of prospective studies.
    Head Neck. 2021 Jul 10. doi: 10.1002/hed.26803.
    PubMed     Abstract available

  341. SHIGA K, Nibu KI, Fujimoto Y, Asakage T, et al
    Sites of invasion of cancer of the external auditory canal predicting oncologic outcomes.
    Head Neck. 2021 Jul 9. doi: 10.1002/hed.26800.
    PubMed     Abstract available

  342. REID P, Staudacher AH, Marcu LG, Olver I, et al
    Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26802.
    PubMed     Abstract available

  343. BADDOUR K, Fadel M, Zhao M, Corcoran M, et al
    The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26801.
    PubMed     Abstract available

  344. CHILLAKURU Y, Benito DA, Strum D, Mehta V, et al
    Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2259-2273.
    PubMed     Abstract available

  345. PFISTER NT, Beitler JJ, Stokes WA
    Contralateral nodal spread in human papillomavirus-associated oropharyngeal cancer: Can more details help guide contralateral neck coverage?
    Head Neck. 2021;43:2253.

  346. HUSAIN S, Lohia S, Petkov V, Blackwell T, et al
    Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.
    Head Neck. 2021;43:2110-2123.
    PubMed     Abstract available

  347. HENN TE, Anderson AN, Hollett YR, Sutton TL, et al
    Circulating hybrid cells predict presence of occult nodal metastases in oral cavity carcinoma.
    Head Neck. 2021;43:2193-2201.
    PubMed     Abstract available

  348. CHEN L, Lin G, Qian J, Chen Z, et al
    A dynamic prognostic nomogram to predict the benefit from surgical treatment modality for patients with laryngeal squamous cell carcinoma.
    Head Neck. 2021;43:2148-2158.
    PubMed     Abstract available

  349. SMITH DK, Freundlich RE, Shinn JR, Wood CB, et al
    An improved predictive model for postoperative pulmonary complications after free flap reconstructions in the head and neck.
    Head Neck. 2021;43:2178-2184.
    PubMed     Abstract available

  350. TOMBLINSON CM, Fletcher GP, Hu LS, Mi L, et al
    Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer.
    Head Neck. 2021;43:2185-2192.
    PubMed     Abstract available

  351. PANNU JS, Simpson MC, Adjei Boakye E, Massa ST, et al
    Survival outcomes for head and neck patients with Medicaid: A health insurance paradox.
    Head Neck. 2021;43:2136-2147.
    PubMed     Abstract available

  352. SAIYED FK, Guo T, Johnson F, Myers JN, et al
    Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2101-2109.
    PubMed     Abstract available

  353. WESTERGAARD-NIELSEN M, Moller S, Godballe C, Grau Eriksen J, et al
    Prognostic scoring models in parotid gland carcinoma.
    Head Neck. 2021;43:2081-2090.
    PubMed     Abstract available

  354. UDOVICICH C, Daniell J, Wiesenfeld D, Bressel M, et al
    Contralateral neck failure in oral tongue cancer: Outcomes from two centers using predefined treatment criteria.
    Head Neck. 2021;43:2024-2031.
    PubMed     Abstract available

  355. CHARTERS E, Wu R, Milross C, Bogaardt H, et al
    Swallowing and communication outcomes following primary transoral robotic surgery.
    Head Neck. 2021;43:2013-2023.
    PubMed     Abstract available

  356. LASKAR SG, Pai P, Sinha S, Budrukkar A, et al
    Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute.
    Head Neck. 2021;43:2045-2057.
    PubMed     Abstract available

  357. HAZIM AZ, Reed CT, Price KA, Foote RL, et al
    Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone.
    Head Neck. 2021;43:1995-2001.
    PubMed     Abstract available

    June 2021
  358. GAO J, Tseng CC, Barinsky GL, Povolotskiy R, et al
    Exploratory analysis on the association of mental health disorders with in-hospital postoperative complications and mortality in head and neck cancer surgery.
    Head Neck. 2021 Jun 28. doi: 10.1002/hed.26791.
    PubMed     Abstract available

  359. BURBURE N, Handorf E, Ridge JA, Bauman J, et al
    Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.
    Head Neck. 2021 Jun 24. doi: 10.1002/hed.26793.
    PubMed     Abstract available

  360. FATEHI KS, Malik A
    Elective neck dissection and its extent in salivary gland cancers: A dilemma.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26777.

  361. WESTERGAARD-NIELSEN M, Godballe C, Eriksen JG, Larsen SR, et al
    Reply to Letter to the Editor regarding "Elective neck dissection and its extent in Salivary gland cancers: A Dilemma".
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26778.

  362. RICH BJ, Schumacher LD, Sargi ZB, Masforroll M, et al
    Opioid use patterns in patients with head and neck cancer receiving radiation therapy: A single-institution retrospective analysis characterizing patients who did not require opioid therapy.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26785.
    PubMed     Abstract available

  363. WEIZMAN B, Golan N, Ronen O
    Effect of socioeconomic status on survival in patients with head and neck cancer.
    Head Neck. 2021 Jun 16. doi: 10.1002/hed.26788.
    PubMed     Abstract available

  364. BERGAMINI C, Ferris RL, Xie J, Mariani G, et al
    Bleeding complications in patients with squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Jun 12. doi: 10.1002/hed.26772.
    PubMed     Abstract available

  365. CAVALHEIRO BG, de Matos LL, Leite AKN, Kulcsar MAV, et al
    Survival in differentiated thyroid carcinoma: A comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system.
    Head Neck. 2021 Jun 1. doi: 10.1002/hed.26773.
    PubMed     Abstract available

  366. WESTERGAARD-NIELSEN M, Godballe C, Grau Eriksen J, Larsen SR, et al
    Surgical treatment of the neck in patients with salivary gland carcinoma.
    Head Neck. 2021;43:1898-1911.
    PubMed     Abstract available

  367. SHEPPARD SC, Borner U, Wartenberg M, Giger R, et al
    Diagnostic use of fine-needle aspiration cytology and core-needle biopsy in head and neck sarcomas.
    Head Neck. 2021;43:1939-1948.
    PubMed     Abstract available

  368. SABIQ F, Huang K, Patel A, Banerjee R, et al
    Novel imaging classification system of nodal disease in human papillomavirus-mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes.
    Head Neck. 2021;43:1854-1863.
    PubMed     Abstract available

  369. HENNOCQ Q, Saintigny P, Quilhot P, Bertolus C, et al
    Association between sex and survival in patients with head and neck spindle cell carcinoma.
    Head Neck. 2021;43:1864-1871.
    PubMed     Abstract available

  370. YANG J, Wei R, Song X, Sun X, et al
    Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis.
    Head Neck. 2021;43:1769-1779.
    PubMed     Abstract available

  371. SAMPLE RA, Wood CB, Mazul AL, Barrett TF, et al
    Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone.
    Head Neck. 2021;43:1759-1768.
    PubMed     Abstract available

  372. LUGINBUHL A, Kahue CN, Stewart M, Curry JM, et al
    Head and neck surgery global outreach: Ethics, planning, and impact.
    Head Neck. 2021;43:1780-1787.
    PubMed     Abstract available

  373. WANG X, Zheng X, Zhu J, Li Z, et al
    Radioactive iodine therapy may not improve disease-specific survival in follicular variant papillary thyroid cancer without distant metastasis: A propensity score-matched analysis.
    Head Neck. 2021;43:1730-1738.
    PubMed     Abstract available

  374. LANISNIK B, Levart P, Cizmarevic B, Svagan M, et al
    Surgeon-performed ultrasound with fine-needle aspiration biopsy for the diagnosis of parotid gland tumors.
    Head Neck. 2021;43:1739-1746.
    PubMed     Abstract available

  375. YAVUZ H, Vural O
    Tracheoesophageal puncture closure with annular mucosal flap.
    Head Neck. 2021;43:1705-1710.
    PubMed     Abstract available

    May 2021
  376. FAGAN JJ, Otiti J, Onakoya PA, Diom E, et al
    AfHNS fellowship: A model to improve access to head and neck cancer care in Africa and developing countries.
    Head Neck. 2021 May 29. doi: 10.1002/hed.26770.
    PubMed     Abstract available

  377. YANG S, Yuan ZJ, Zhu YH, Chen X, et al
    lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p.
    Head Neck. 2021 May 25. doi: 10.1002/hed.26742.
    PubMed     Abstract available

  378. CIVANTOS AM, Prasad A, Carey RM, Bur AM, et al
    Palliative care in metastatic head and neck cancer.
    Head Neck. 2021 May 21. doi: 10.1002/hed.26761.
    PubMed     Abstract available

  379. GOSHTASBI K, Abiri A, Lehrich BM, Haidar YM, et al
    The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26739.
    PubMed     Abstract available

  380. PANG J, Faraji F, Risa E, Mell LK, et al
    High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26736.
    PubMed     Abstract available

  381. HOESSEINI A, van Leeuwen N, Offerman MPJ, Zhang J, et al
    Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.
    Head Neck. 2021 May 7. doi: 10.1002/hed.26716.
    PubMed     Abstract available

  382. RIJO-CEDENO J, Mucientes J, Seijas Marcos S, Romero J, et al
    Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26725.
    PubMed     Abstract available

  383. VERMAIRE JA, Terhaard CHJ, Verdonck-de Leeuw IM, Raaijmakers CPJ, et al
    Reliability of the 100 mL water swallow test in patients with head and neck cancer and healthy subjects.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26723.
    PubMed     Abstract available

  384. LIAO W, He J, Gou Q, Duan B, et al
    Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26706.
    PubMed     Abstract available

  385. CHANG JW, Lee S, Lee JM, Moon IS, et al
    Occult parotid involvement in early-stage squamous cell carcinoma of the external auditory canal.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26729.
    PubMed     Abstract available

  386. DE VIRGILIO A, Kim SH, Wang CC, Holsinger FC, et al
    Anatomical-based classification for transoral base of tongue resection.
    Head Neck. 2021;43:1604-1609.
    PubMed     Abstract available

  387. OTTENSTEIN L, Cornett H, Switchenko JM, Nathan M, et al
    Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
    Head Neck. 2021;43:1629-1640.
    PubMed     Abstract available

  388. DE VIRGILIO A, Costantino A, Ferreli F, Malvezzi L, et al
    High-definition three-dimensional exoscope for head and neck reconstruction: Prospective analysis of 27 consecutive patients.
    Head Neck. 2021;43:1574-1580.
    PubMed     Abstract available

  389. SUNG YE, Kim MS, Lee YS
    Proposal of a scoring system for predicting pathological risk based on a semiautomated analysis of whole slide images in oral squamous cell carcinoma.
    Head Neck. 2021;43:1581-1591.
    PubMed     Abstract available

  390. LIM Y, Tang KD, Karpe AV, Beale DJ, et al
    Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer.
    Head Neck. 2021;43:1521-1534.
    PubMed     Abstract available

  391. TAM S, Gajera M, Luo X, Glisson BS, et al
    Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.
    Head Neck. 2021;43:1592-1603.
    PubMed     Abstract available

  392. YOUNG A, Bigcas JL, Yang A, Reeve N, et al
    Transoral robotic submandibular gland transposition to reconstruct radical tonsillar resection defects.
    Head Neck. 2021;43:1695-1698.
    PubMed     Abstract available

  393. GUALTIERI T, Verzeletti V, Ferrari M, Perotti P, et al
    A new landmark for lingual artery identification during transoral surgery: Anatomic-radiologic study.
    Head Neck. 2021;43:1487-1498.
    PubMed     Abstract available

  394. SMITH AW, Gallitto M, Lehrer EJ, Wasserman I, et al
    Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.
    Head Neck. 2021;43:1409-1414.
    PubMed     Abstract available

  395. MOLTENI G, Gazzini L, Sacchetto A, Nocini R, et al
    Role of the temporoparietal fascia free flap in salvage total laryngectomy.
    Head Neck. 2021;43:1692-1694.
    PubMed     Abstract available

  396. LIU HY, Daniels CP, Trada Y, Bernard A, et al
    The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2021;43:1440-1450.
    PubMed     Abstract available

  397. NOCON CC, Kuchta K, Bhayani MK
    Prognostic value of lymph node ratio versus American Joint Committee on Cancer N classification for surgically resected human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:1476-1486.
    PubMed     Abstract available

    April 2021
  398. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 Apr 27. doi: 10.1002/hed.26726.
    PubMed     Abstract available

  399. HIGHLAND J, Aylward A, Do O, Monroe M, et al
    Trust in physicians among patients with head and neck cancer before and after treatment.
    Head Neck. 2021 Apr 26. doi: 10.1002/hed.26721.
    PubMed     Abstract available

  400. SEKI-SODA M, Sano T, Ogawa M, Yokoo S, et al
    CD15(+) tumor infiltrating granulocytic cells can predict recurrence and their depletion is accompanied by good responses to S-1 with oral cancer.
    Head Neck. 2021 Apr 24. doi: 10.1002/hed.26712.
    PubMed     Abstract available

  401. NUYTS S, Bollen H, Eisbruch A, Corry J, et al
    Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Apr 19. doi: 10.1002/hed.26713.
    PubMed     Abstract available

  402. MESSING BP, Ward EC, Lazarus C, Ryniak K, et al
    Longitudinal comparisons of a whole-mouth taste test to clinician-rated and patient-reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake.
    Head Neck. 2021 Apr 15. doi: 10.1002/hed.26690.
    PubMed     Abstract available

  403. WANG SM, Yin SC, Su XZ, Xu Q, et al
    Magnitude of radial forearm free flaps and factors associated with loss of volume in oral cancer reconstructive surgery: A prospective study.
    Head Neck. 2021 Apr 13. doi: 10.1002/hed.26704.
    PubMed     Abstract available

  404. WIBONELE BK, Smith BD, Altonji S, Kaplan S, et al
    Head and neck cancer research collaborations between the United States and low- and middle-income countries: A 10-year publication analysis.
    Head Neck. 2021 Apr 5. doi: 10.1002/hed.26703.
    PubMed     Abstract available

  405. YANG N, Mercier E, Guertin L, Bissada E, et al
    Development, translation, and preliminary validation of the neck dissection assessment tool.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26696.
    PubMed     Abstract available

  406. SMITS HJG, Assili S, Kauw F, Philippens MEP, et al
    Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic and meta-analysis.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26698.
    PubMed     Abstract available

  407. ZAKERI K, Wang H, Kang JJ, Lee A, et al
    Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy.
    Head Neck. 2021;43:1056-1062.
    PubMed     Abstract available

  408. SCHVARTSMAN G, Bell D, Rubin ML, Tetzlaff M, et al
    The tumor immune contexture of salivary duct carcinoma.
    Head Neck. 2021;43:1213-1219.
    PubMed     Abstract available

  409. XING MH, Mundi N, Govindan A, Khorsandi A, et al
    Unusual location of a second branchial cleft cyst presenting in the suprasternal notch.
    Head Neck. 2021;43:E27-E29.
    PubMed     Abstract available

  410. BALASUBRAMANIAN D, Subramaniam N, Missale F, Marchi F, et al
    Predictive nomograms for oral tongue squamous cell carcinoma applying the American Joint Committee on Cancer/Union Internationale Contre le Cancer 8th edition staging system.
    Head Neck. 2021;43:1043-1055.
    PubMed     Abstract available

  411. DONG P, Wang L, Qu Y, Huang R, et al
    Low- and high-dose radioiodine ablation for low-/intermediate-risk differentiated thyroid cancer in China: Large randomized clinical trial.
    Head Neck. 2021;43:1311-1320.
    PubMed     Abstract available

  412. MASHRAH MA, Aldhohrah T, Abdelrehem A, Koraitim M, et al
    What is the best method for prevention of postparotidectomy Frey syndrome? Network meta-analysis.
    Head Neck. 2021;43:1345-1358.
    PubMed     Abstract available

  413. STACK BC JR, Twining C, Rastatter J, Angelos P, et al
    Consensus statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS-ES) on Pediatric Benign and Malignant Thyroid Surgery.
    Head Neck. 2021;43:1027-1042.
    PubMed     Abstract available

  414. ATALLAH I, Castellanos PF
    Transoral closure of the supraglottic larynx for intractable aspiration.
    Head Neck. 2021;43:1370-1375.
    PubMed     Abstract available

  415. SINHA S, Agarwal JP, Mahajan A, Chaturvedi P, et al
    Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study.
    Head Neck. 2021;43:1289-1299.
    PubMed     Abstract available

  416. MCKENZIE RM, Parhar HS, Ng TL, Prisman E, et al
    Muscle invasion in oropharyngeal carcinoma undergoing transoral robotic surgery.
    Head Neck. 2021;43:1194-1201.
    PubMed     Abstract available

  417. CAREY RM, Shimunov D, Weinstein GS, Cannady SB, et al
    Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy.
    Head Neck. 2021;43:1128-1141.
    PubMed     Abstract available

  418. LIU WC, Liu HE, Kao YW, Qin L, et al
    Definitive intensity-modulated radiotherapy or surgery for early oral cavity squamous cell carcinoma: Propensity-score-matched, nationwide, population-based cohort study.
    Head Neck. 2021;43:1142-1152.
    PubMed     Abstract available

  419. SUN M, Wang K, Qu Y, Zhang J, et al
    Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
    Head Neck. 2021;43:1097-1104.
    PubMed     Abstract available

  420. KUMAR A, Laskar SG, Thiagarajan S
    Is Transoral Robotic Surgery (TORS) for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1376-1377.

  421. BATES JE, Amdur RJ
    In reply to Kumar et al, Is TORS for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1378-1379.

  422. ROOKER SA, Van Abel KM, Yin LX, Nagelschneider AA, et al
    Risk factors for subsequent recurrence after surgical treatment of recurrent pleomorphic adenoma of the parotid gland.
    Head Neck. 2021;43:1088-1096.
    PubMed     Abstract available

  423. SARI SY, Yilmaz MT, Elmali A, Yedekci FY, et al
    Parotid gland stem cells: Mini yet mighty.
    Head Neck. 2021;43:1122-1127.
    PubMed     Abstract available

    March 2021
  424. TODSEN T, Bennedbaek FN, Kiss K, Hegedus L, et al
    Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules.
    Head Neck. 2021;43:1009-1013.
    PubMed     Abstract available

  425. DAVIES L
    Why are there different conclusions about thyroid cancer mortality?
    Head Neck. 2021;43:984-986.

  426. LABARGE B, Walter V, Bann DV, Goldenberg D, et al
    In-depth analysis of thyroid cancer mortality.
    Head Neck. 2021;43:977-983.
    PubMed     Abstract available

  427. LYU X, Liu S, Zheng L, Huang M, et al
    New approach to an overlooked flap: Technique to augment venous drainage of the infrahyoid myocutaneous flap.
    Head Neck. 2021;43:942-948.
    PubMed     Abstract available

  428. COLAIANNI CA, Feng AL, Richmon JD
    Partial parotidectomy via periauricular incision: Retrospective cohort study and comparative analysis to alternative incisional approaches.
    Head Neck. 2021;43:825-832.
    PubMed     Abstract available

  429. GUNTINAS-LICHIUS O, Thielker J, Robbins KT, Olsen KD, et al
    Prognostic role of intraparotid lymph node metastasis in primary parotid cancer: Systematic review.
    Head Neck. 2021;43:997-1008.
    PubMed     Abstract available

  430. DOESCHER J, Minkenberg P, Laban S, Kostezka U, et al
    Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy.
    Head Neck. 2021;43:778-787.
    PubMed     Abstract available

  431. SWARTZ JE, Wegner I, Noorlag R, van Kempen PMW, et al
    HIF-1a expression and differential effects on survival in patients with oral cavity, larynx, and oropharynx squamous cell carcinomas.
    Head Neck. 2021;43:745-756.
    PubMed     Abstract available

  432. SULLIVAN CB, Al-Qurayshi Z, Chang K, Pagedar NA, et al
    Analysis of palliative care treatment among head and neck patients with cancer: National perspective.
    Head Neck. 2021;43:805-815.
    PubMed     Abstract available

    February 2021
  433. VAN DER LANS RJL, Engel MSD, Rijken JA, Hensen EF, et al
    Neuroendocrine neoplasms of the middle ear: Unpredictable tumor behavior and tendency for recurrence.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26658.
    PubMed     Abstract available

  434. HOLCOMB AJ, Richmon JD
    Transoral robotic salvage oropharyngectomy with submental artery island flap reconstruction.
    Head Neck. 2021;43:E13-E19.
    PubMed     Abstract available

  435. DE VIRGILIO A, Costantino A, Canzano F, Accorona R, et al
    Regional disease control in sinonasal mucosal melanoma: Systematic review and meta-analysis.
    Head Neck. 2021;43:705-715.
    PubMed     Abstract available

  436. REED R, Strumpf A, Martz TG, Kavanagh KJ, et al
    2015 American Thyroid Association guidelines and thyroid-stimulating hormone suppression after thyroid lobectomy.
    Head Neck. 2021;43:639-644.
    PubMed     Abstract available

  437. LUK PP, Ebrahimi A, Veness MJ, McDowell L, et al
    Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study.
    Head Neck. 2021;43:558-567.
    PubMed     Abstract available

  438. LAO WP, Lagabon KJ, Arom GA, Walker PC, et al
    Combined endoscopic and transoral resection of a high-staged juvenile nasopharyngeal angiofibroma: A pictorial essay.
    Head Neck. 2021;43:719-724.
    PubMed     Abstract available

  439. BINZ GHA, Soyka MB, Holzmann D, Meerwein CM, et al
    Need for long-term follow-up in sinonasal inverted papilloma: A Single-institution experience.
    Head Neck. 2021;43:630-638.
    PubMed     Abstract available

  440. SMITHERS FAE, Haymerle G, Palme CE, Low TH, et al
    A prospective study of intraoperative assessment of mucosal squamous cell carcinoma margins in the head and neck.
    Head Neck. 2021;43:590-600.
    PubMed     Abstract available

  441. HUM L, Bethmann D, Feng Z, Chang SC, et al
    Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection margins.
    Head Neck. 2021;43:568-576.
    PubMed     Abstract available

  442. PINATTI LM, Sinha HN, Brummel CV, Goudsmit CM, et al
    Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:544-557.
    PubMed     Abstract available

  443. HUANG SH, de Almeida JR, Watson E, Glogauer M, et al
    Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma.
    Head Neck. 2021;43:456-466.
    PubMed     Abstract available

  444. SU WW, Lee YH, Yen AM, Chen SL, et al
    Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening program.
    Head Neck. 2021;43:473-484.
    PubMed     Abstract available

  445. YIN LX, Van Abel KM, Rooker SA, Nagelschneider AA, et al
    Risk factors for carcinoma ex pleomorphic adenoma in patients presenting with recurrence after resection of pleomorphic adenoma.
    Head Neck. 2021;43:419-427.
    PubMed     Abstract available

  446. BOS P, van den Brekel MWM, Gouw ZAR, Al-Mamgani A, et al
    Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer.
    Head Neck. 2021;43:485-495.
    PubMed     Abstract available

  447. KIKUCHI M, Yamashita D, Hara S, Takebayashi S, et al
    Clinical significance of tumor-associated immune cells in patients with oral squamous cell carcinoma.
    Head Neck. 2021;43:534-543.
    PubMed     Abstract available

  448. ARUN I, Maity N, Hameed S, Jain PV, et al
    Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
    Head Neck. 2021;43:520-533.
    PubMed     Abstract available

  449. BASIM P, Argun D, Ozdenkaya Y
    Self-reported medication adherence in differentiated thyroid cancer survivors: Role of illness perception and medication beliefs.
    Head Neck. 2021;43:428-437.
    PubMed     Abstract available

    January 2021
  450. JOZAGHI Y, Zafereo M, Williams MD, Gule-Monroe MK, et al
    Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
    Head Neck. 2021;43:E7-E12.
    PubMed     Abstract available

  451. WANG Y, Zhou S, Liu X, Rui S, et al
    Transoral endoscopic thyroidectomy vestibular approach vs conventional open thyroidectomy: Meta-analysis.
    Head Neck. 2021;43:345-353.
    PubMed     Abstract available

  452. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Bipedicled submental musculofascial "hammock" flap for salvage laryngectomy closure reinforcement.
    Head Neck. 2021;43:198-202.
    PubMed     Abstract available

  453. PATEL KB, Martin D, Zhao S, Kumar B, et al
    Impact of age and comorbidity on survival among patients with oral cavity squamous cell carcinoma.
    Head Neck. 2021;43:268-277.
    PubMed     Abstract available

  454. SHARBEL DD, Abkemeier M, Sullivan J, Zimmerman Z, et al
    Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:334-344.
    PubMed     Abstract available

  455. MOORE EJ, Van Abel KM, Routman DM, Lohse CM, et al
    Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
    Head Neck. 2021;43:229-237.
    PubMed     Abstract available

  456. CLARK CM, Newark AC, Fokar A, Maxwell JH, et al
    Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwide Veterans Affairs database study.
    Head Neck. 2021;43:247-254.
    PubMed     Abstract available

  457. FUNG AS, Afzal AR, Banerjee R, Debenham B, et al
    A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma.
    Head Neck. 2021;43:153-163.
    PubMed     Abstract available

  458. PANUGANTI BA, Stuart E, Weissbrod P
    Changes in treatment trends in the early glottic cancer population after the Affordable Care Act.
    Head Neck. 2021;43:137-144.
    PubMed     Abstract available

  459. CHWEYA CM, Low CM, Van Gompel JJ, Van Abel KM, et al
    Population-based analysis on the effect of nodal and distant metastases in sinonasal adenocarcinoma.
    Head Neck. 2021;43:128-136.
    PubMed     Abstract available

  460. GRANT-FREEMANTLE MC, Lane O'Neill B, Clover AJP
    The effectiveness of radiotherapy in the treatment of head and neck mucosal melanoma: Systematic review and meta-analysis.
    Head Neck. 2021;43:323-333.
    PubMed     Abstract available

  461. LIU SW, Woody NM, Wei W, Appachi S, et al
    Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration study.
    Head Neck. 2021;43:60-69.
    PubMed     Abstract available

  462. ZEVALLOS JP, Kramer JR, Sandulache VC, Massa ST, et al
    National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System.
    Head Neck. 2021;43:108-115.
    PubMed     Abstract available

  463. YAN F, Desiato VM, Nguyen SA, Lentsch EJ, et al
    Impact of greater auricular nerve sacrifice during parotidectomy on quality of life.
    Head Neck. 2021;43:70-78.
    PubMed     Abstract available

    August 2020
  464. NABUURS CH, Kievit W, Labbe N, Leemans CR, et al
    Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26424.
    PubMed     Abstract available

    September 2019
  465. BALAGUER M, Pommee T, Farinas J, Pinquier J, et al
    Effects of oral and oropharyngeal cancer on speech intelligibility using acoustic analysis: Systematic review.
    Head Neck. 2019 Sep 30. doi: 10.1002/hed.25949.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.